Chapter review

Must know

• The Three Ds: Clinical TriadThe Three Ds of geriatric psychiatry represent the clinical triad of depression, dementia (major neurocognitive disorder), and delirium.

  • The Three Ds of geriatric psychiatry represent the clinical triad of depression, dementia (major neurocognitive disorder), and delirium.
  • Standardized depression screening instruments, such as the PHQ-9, are fully valid and effective for adults over 65 years of age across community, acute, and nursing home settings.
  • Advancing age is not an independent risk factor for developing major depressive disorder, despite the accumulation of physical and psychosocial losses in late life.
  • Older adults who commit suicide frequently communicate their intent beforehand through direct verbal statements, indirect comments, or behavioral cues like giving away personal possessions.
  • Up to 50 percent of patients diagnosed with major neurocognitive disorder suffer from co-occurring major depression, requiring routine screening and targeted treatment.
  • Delirium is an acute disturbance in attention and awareness that develops over hours to days, fluctuates in severity throughout the day, and is caused by an underlying medical condition, substance toxicity, or withdrawal.
• Screening Myths and Geriatric TruthsClinical evaluation of the older adult requires dispelling common misconceptions regarding mood, aging, and cognitive decline.

  • Clinical evaluation of the older adult requires dispelling common misconceptions regarding mood, aging, and cognitive decline.
  • **Board trap.** Exam questions frequently present an elderly patient with mood changes and tempt test-takers to view depression as an inevitable, normal part of aging.
  • Advancing age alone is not an independent risk factor for **major depressive disorder**.
  • When an older adult presents with depressive symptoms, conduct a formal evaluation rather than dismissing the presentation as normal aging.

  Board trap. Exam questions frequently present an elderly patient with mood changes and tempt test-takers to view depression as an inevitable, normal part of aging. Advancing age alone is not an independent risk factor for major depressive disorder. When an older adult presents with depressiv

  Safety. Older adults represent a high-risk demographic for completed suicide, particularly elderly white males. Contrary to common belief, suicidal elders usually communicate their plans prior to an attempt. Verbal statements, indirect comments regarding being a burden, or giving away pe

• Differentiating the Three DsFirst-line pharmacotherapy for late-life depression consists of SSRIs started at low doses and titrated slowly to therapeutic effect. Clinicians must obtain baseline renal and hepatic labs and monitor serum sodium levels due to the risk of hyponatremia. For severe, psychotic, or

  • The primary diagnostic responsibility in geriatric psychiatry is distinguishing among **depression**, **dementia**, and **delirium**.
  • **Delirium** presents as an acute onset of impaired attention, reduced environmental awareness, and global cognitive disturbance.
  • Symptoms emerge rapidly over hours to days and characteristically fluctuate throughout the day, often worsening in the evening hours.
  • **Delirium** is secondary to a direct physiological etiology, such as urinary tract infections, electrolyte imbalances like **hyponatremia**, or anticholinergic medication toxicity.
• Advanced age is an independent risk factor for developing major depressionC. True only in male patients

  • C. True only in male patients
  • D. True only in hospitalized patients
  • Why correct: Advancing age itself is not an independent risk factor for developing major depressive disorder, although aging is frequently accompanied by an accumulation of physical, social, and functional losses.
  • Why the other choices are wrong:
  • A: Incorrect because aging alone does not independently cause or predict major depression.
  • C: Incorrect because gender does not make age an independent risk factor.
• Most elderly persons who commit suicide do not talk about their plansC. True only among women

  • C. True only among women
  • D. True only among patients with dementia
  • Why correct: Older adults who commit suicide frequently communicate their intent prior to an attempt through direct verbal expressions, indirect statements, or explicit behaviors like giving away personal possessions.
  • Why the other choices are wrong:
  • A: Incorrect because suicidal elders usually give explicit or implicit warnings before acting.
  • C: Incorrect because both elderly men and women communicate suicidal ideation prior to attempts.
• Initial Diagnostic Workup ProtocolsStandardized depression screening tools like the PHQ-9 and GDS are valid in adults over 65 years of age. Advancing age alone is not an independent risk factor for major depressive disorder, though up to 50% of patients with major NCD have co-occurring depression.

  • Standardized depression screening tools like the PHQ-9 and GDS are valid in adults over 65 years of age. Advancing age alone is not an independent risk factor for major depressive disorder, though up to 50% of patients with major NCD have co-occurring depression.
  • ApoE e4 allele genetic testing is not recommended for routine clinical use, but genetic testing is indicated for suspected early-onset Alzheimer's disease occurring before age 65 (accounting for less than 5% of cases).
  • Neuroimaging with head CT or MRI is indicated in the initial diagnostic evaluation of major NCD to rule out structural causes such as subdural hematoma, normal pressure hydrocephalus, or cerebrovascular disease.
  • Antipsychotics carry an FDA Black Box Warning for increased mortality (1.6 to 1.7 times higher risk, primarily cardiovascular or pneumonia) in elderly patients with NCD-related psychosis, and must be reserved strictly for severe agitation or immediate safety risks.
  • Electroconvulsive therapy (ECT) is safe and effective for adults over 65 years of age with severe, psychotic, or treatment-resistant depression.
• Core Clinical ObjectivesDifferentiate the three Ds: depression, dementia (major neurocognitive disorder), and delirium.

  • Differentiate the three Ds: depression, dementia (major neurocognitive disorder), and delirium.
  • Identify reversible or correctable medical contributors to cognitive decline (found in 2% to 5% of cases, such as normal pressure hydrocephalus, subdural hematoma, or hypothyroidism).
  • Establish an objective cognitive baseline using validated tools (MoCA, SLUMS, MMSE, Mini-Cog).
  • Assess functional capacity across ADLs (bathing, dressing, toileting, grooming) and IADLs (preparing meals, managing finances, doing laundry, house cleaning).
  • Evaluate for co-occurring mood disorders, as depression co-occurs in up to 50% of individuals with major NCD.
• Baseline Laboratory Workup for Major Neurocognitive Disorder1. CBC (Complete Blood Count) to evaluate for anemia, infection, or hematologic pathology.

  • 1. CBC (Complete Blood Count) to evaluate for anemia, infection, or hematologic pathology.
  • 2. TSH (Thyroid Stimulating Hormone) to rule out hypothyroidism or hyperthyroidism.
  • 3. Vitamin B12 and folate levels. If vitamin B12 is in the low-normal range, order methylmalonic acid (MMA) or homocysteine levels to confirm cellular deficiency.
  • 4. CMP (Comprehensive Metabolic Panel) to assess serum glucose, electrolytes (sodium, potassium), renal function (BUN, creatinine), liver function tests, serum albumin, and total protein.
  • 5. Urinalysis (UA) to detect occult urinary tract infection.
  • 6. Infectious disease screening including RPR or VDRL for neurosyphilis and HIV testing.
• Differentiating Acute Delirium Workup vs Chronic NCD EvaluationAcute mental status changes occurring over hours to days signal delirium, which is a medical emergency.

  • Acute mental status changes occurring over hours to days signal delirium, which is a medical emergency.
  • First-line initial labs for acute delirium focus on immediate physical rule-outs: serum glucose, urinalysis, CMP, CBC, and EKG.
  • Selecting a head CT scan or HIV test as the initial priority for acute delirium without focal neurological deficits or trauma. Metabolic, infectious, and cardiac causes must be evaluated first.
  • Structural neuroimaging (head CT or MRI) is essential during the comprehensive workup of major NCD to identify subdural hematoma, vascular NCD infarcts, or normal pressure hydrocephalus.

  Board trap. Selecting a head CT scan or HIV test as the initial priority for acute delirium without focal neurological deficits or trauma. Metabolic, infectious, and cardiac causes must be evaluated first.

  Safety. Acute mental status changes occurring over hours to days signal delirium, which is a medical emergency.

• Specialized Diagnostic Testing RulesGenetic testing for the ApoE e4 allele is not recommended for routine clinical diagnosis of Alzheimer's disease.

  • Genetic testing for the ApoE e4 allele is not recommended for routine clinical diagnosis of Alzheimer's disease.
  • Genetic testing is indicated for early-onset Alzheimer's disease presenting before age 65, which represents less than 5% of cases.
  • Neuropsychological testing is indicated for diagnostic clarity, establishing objective baselines, assessing functional competency, and designing rehabilitation strategies.
• Prescribing Safety and Medication Rule-OutsFirst-line pharmacotherapy for co-occurring depression or anxiety in older adults is an SSRI such as sertraline.

  • First-line pharmacotherapy for co-occurring depression or anxiety in older adults is an SSRI such as sertraline.
  • SSRIs increase the risk of hyponatremia (SIADH), especially when combined with diuretics like hydrochlorothiazide or lisinopril. Check serum sodium if confusion or falls occur.
  • Avoid tricyclic antidepressants like amitriptyline due to severe anticholinergic side effects (dry mouth, constipation, blurry vision, urinary retention) and anticholinergic delirium.
  • Avoid zolpidem due to increased fall and fracture risks.

  Board trap. Avoid tricyclic antidepressants like amitriptyline due to severe anticholinergic side effects (dry mouth, constipation, blurry vision, urinary retention) and anticholinergic delirium.

  Safety. SSRIs increase the risk of hyponatremia (SIADH), especially when combined with diuretics like hydrochlorothiazide or lisinopril. Check serum sodium if confusion or falls occur.

• DSM-5-TR Diagnostic Criteria for DeliriumDiagnostic Timeline: Symptoms develop abruptly over hours to days with a fluctuating course that often worsens at night (sundowning).

  • Diagnostic Timeline: Symptoms develop abruptly over hours to days with a fluctuating course that often worsens at night (sundowning).
  • Core Diagnostic Feature: Reduced ability to direct, focus, sustain, or shift attention and reduced orientation to the environment.
  • Cognitive Disturbance: Memory deficits, disorientation, language impairment, or visuospatial dysfunction not explained by pre-existing neurocognitive disorders.
  • Physical Etiology: Required evidence that symptoms are the direct physiological consequence of a medical condition, substance toxicity, or withdrawal.
  • Motor Subtypes: Hyperactive (25%), hypoactive (25%), mixed (35%), or no motor change (15%). Hypoactive delirium is most frequently missed.
  • High Prevalence: Occurs in up to 80% of geriatric ICU admissions and up to 40% of nursing home residents.
• DSM-5-TR Diagnostic CriteriaCriterion A: Disturbance in attention (reduced ability to direct, focus, sustain, and shift attention) and awareness (reduced orientation to the environment).

  • Criterion A: Disturbance in attention (reduced ability to direct, focus, sustain, and shift attention) and awareness (reduced orientation to the environment).
  • Criterion B: The disturbance develops over a short period of time (typically hours to a few days), represents a change from baseline attention and awareness, and tends to fluctuate in severity throughout the day.
  • Criterion C: An additional disturbance in cognition (memory deficit, disorientation, language, visuospatial ability, or perception).
  • Criterion D: The disturbances in Criteria A and C are not better explained by another pre-existing, established, or evolving neurocognitive disorder and do not occur in the context of a severely reduced level of arousal, such as coma.
  • Criterion E: Evidence from the history, physical examination, or laboratory findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal, exposure to a toxin, or multiple etiologies.
• Critical SignpostsImmediate physical assessment, vital signs, and baseline laboratory workup (serum glucose, urinalysis, electrolytes, CBC, CMP, EKG) to identify and reverse the underlying medical cause.

  • Delirium is a medical emergency with high mortality if unrecognized. Between one-third and two-thirds of cases are missed by clinicians.
  • Assuming acute agitation or confusion in an older adult is worsening dementia or late-onset psychosis. Always rule out acute medical causes before diagnosing a primary psychiatric illness.
  • Immediate physical assessment, vital signs, and baseline laboratory workup (serum glucose, urinalysis, electrolytes, CBC, CMP, EKG) to identify and reverse the underlying medical cause.
  • First-line non-pharmacologic intervention: Reorientation, environmental calm, adequate hydration, pain management, and restoring sensory aids (glasses and hearing aids).

  Board trap. Assuming acute agitation or confusion in an older adult is worsening dementia or late-onset psychosis. Always rule out acute medical causes before diagnosing a primary psychiatric illness.

  Safety. Delirium is a medical emergency with high mortality if unrecognized. Between one-third and two-thirds of cases are missed by clinicians.

• Clinical Features and Etiology MnemonicD - Drugs: Addition of new medications, dose adjustments, or toxicity from systemic anticholinergics, tricyclic antidepressants, first-generation antihistamines, first-generation antipsychotics, opioids, benzodiazepines, or alcohol.

  • D - Drugs: Addition of new medications, dose adjustments, or toxicity from systemic anticholinergics, tricyclic antidepressants, first-generation antihistamines, first-generation antipsychotics, opioids, benzodiazepines, or alcohol.
  • E - Emotional or Electrolyte: Severe depression or bereavement; hyponatremia and other acute electrolyte imbalances.
  • L - Low oxygen or Lack of drugs: Hypoxemia from pneumonia, COPD, myocardial infarction, or pulmonary embolism; withdrawal from alcohol or sedatives.
  • I - Infection: Urinary tract infection (UTI) and community-acquired pneumonia are the two most common infectious triggers in older adults.
  • R - Retention or Reduced sensory input: Urinary or fecal retention; loss of eyeglasses or hearing aids.
  • I - Ictal state: Post-ictal state or alcohol withdrawal seizures.
• Comparing Delirium and Neurocognitive DisordersOnset: Delirium is abrupt over hours to days. Major neurocognitive disorder is insidious over months to years.

  • Onset: Delirium is abrupt over hours to days. Major neurocognitive disorder is insidious over months to years.
  • Course: Delirium fluctuates hour to hour. Dementia is slow and progressive.
  • Attention: Delirium severely impairs attention and level of consciousness early. Dementia preserves attention until advanced stages.
  • Reversibility: Delirium is potentially reversible once the underlying cause is resolved. Dementia is chronic and irreversible.
• Table: Clinical Assessment of DeliriumOnset timeline: Delirium features an abrupt onset developing over hours to days with hour-to-hour fluctuating severity and impaired attention.

  • Onset timeline: Delirium features an abrupt onset developing over hours to days with hour-to-hour fluctuating severity and impaired attention.
  • Epidemiology numbers: Between 33% and 66% of delirium cases go unrecognized; incidence reaches up to 80% in geriatric ICU admissions and up to 40% in nursing home residents.
  • Psychomotor subtypes: Mixed psychomotor presentation occurs in 35% of cases, hyperactive in 25%, hypoactive in 25%, and no psychomotor change in 15%.
  • Diagnostic criteria: Core features require a disturbance in attention and awareness developing rapidly, representing a acute decline from baseline, caused by direct physiological triggers, medical illness, or drug toxicity.
  • Medication precipitants: High-risk precipitants include anticholinergics like diphenhydramine, sedatives like diazepam, and typical antipsychotics like haloperidol, whereas SSRIs like sertraline are least likely to precipitate delirium.
  • Initial diagnostic workup: Prioritize serum glucose, urinalysis, CBC, CMP, and EKG to identify acute physical causes before ordering a head CT scan or HIV testing.
• Core Features and Cognitive AssessmentHypoactive delirium occurs in 25% of patients and is frequently missed because patients appear quiet, passive, or lethargic. Missing hypoactive delirium delays medical treatment for underlying infections or metabolic crises, leading to higher mortality.

  • Hypoactive delirium occurs in 25% of patients and is frequently missed because patients appear quiet, passive, or lethargic. Missing hypoactive delirium delays medical treatment for underlying infections or metabolic crises, leading to higher mortality.
  • Confusing acute delirium with progressing dementia. Dementia features an insidious onset over months to years with stable alertness, whereas delirium presents with abrupt onset over hours to days, a fluctuating course, and marked inattention.

  Board trap. Confusing acute delirium with progressing dementia. Dementia features an insidious onset over months to years with stable alertness, whereas delirium presents with abrupt onset over hours to days, a fluctuating course, and marked inattention.

  Safety. Hypoactive delirium occurs in 25% of patients and is frequently missed because patients appear quiet, passive, or lethargic. Missing hypoactive delirium delays medical treatment for underlying infections or metabolic crises, leading to higher mortality.

• Epidemiology and EtiologyWhen an older adult presents with acute confusion, the initial clinical priority is stabilizing physical safety, assessing oxygenation, and searching for underlying reversible medical causes before administering psychotropic medications.

  • When an older adult presents with acute confusion, the initial clinical priority is stabilizing physical safety, assessing oxygenation, and searching for underlying reversible medical causes before administering psychotropic medications.
• Psychomotor and Speech PatternsMixed presentation: Accounts for 35% of cases, fluctuating between hyperactive agitation and hypoactive lethargy.

  • Mixed presentation: Accounts for 35% of cases, fluctuating between hyperactive agitation and hypoactive lethargy.
  • Hyperactive presentation: Accounts for 25% of cases, featuring agitation, hyperalertness, and restlessness.
  • Hypoactive presentation: Accounts for 25% of cases, featuring lethargy, psychomotor slowing, and apathy.
  • Unchanged motor activity: Accounts for 15% of cases, maintaining normal motor speed despite severe inattention.
• Mnemonic: The DELIRIUMS EtiologyDelirium is a medical emergency characterized by an acute disturbance in attention and awareness that develops over hours to days and fluctuates in severity throughout the day.

  • Delirium is a medical emergency characterized by an acute disturbance in attention and awareness that develops over hours to days and fluctuates in severity throughout the day.
  • Up to two-thirds of delirium cases go unrecognized in clinical practice, despite occurring in up to 80% of geriatric intensive care unit admissions and 40% of nursing home residents.
  • Infection, specifically urinary tract infection and community-acquired pneumonia, represents the single most common physical cause of acute cognitive decline in older adults.
  • Medications with high anticholinergic activity, such as diphenhydramine and tricyclic antidepressants, along with benzodiazepines and opioids, are major pharmacological drivers of delirium.
  • Hyponatremia caused by selective serotonin reuptake inhibitors combined with thiazide diuretics frequently precipitates acute confusion, weakness, and falls in geriatric patients.
  • Initial diagnostic evaluation for acute mental status changes requires immediate laboratory workup including a complete blood count, comprehensive metabolic panel, urinalysis, fingerstick glucose, and EKG before neuroimaging like a head CT scan.
• Safety AlertHyponatremia and severe anticholinergic toxicity represent urgent physical hazards in geriatric psychiatry. Always inspect over-the-counter medications for diphenhydramine when evaluating a patient with new-onset confusion or restlessness.

  • Hyponatremia and severe anticholinergic toxicity represent urgent physical hazards in geriatric psychiatry. Always inspect over-the-counter medications for diphenhydramine when evaluating a patient with new-onset confusion or restlessness.
• Executive SummaryDepression screening tool validity: Standardized depression screening instruments, including the PHQ-9 and the Geriatric Depression Scale, are fully validated and clinically reliable for adults aged 65 years and older in outpatient, inpatient, and long-term care settings.

  • Depression screening tool validity: Standardized depression screening instruments, including the PHQ-9 and the Geriatric Depression Scale, are fully validated and clinically reliable for adults aged 65 years and older in outpatient, inpatient, and long-term care settings.
  • Age is not an independent cause: Advancing age itself is not an independent risk factor for major depressive disorder, even though late life brings cumulative psychosocial and functional losses.
  • Suicide intent communication: Older adults who commit suicide frequently communicate their intent prior to the act through direct statements, indirect comments, or behavioral changes such as giving away personal belongings.
  • High comorbidity with dementia: Up to 50% of individuals diagnosed with a major neurocognitive disorder also suffer from co-occurring major depressive disorder.
  • The Three Ds of geriatric psychiatry: Clinical evaluation in older adults revolves around differentiating depression, dementia (major neurocognitive disorder), and delirium.
  • First-line pharmacotherapy: SSRIs are preferred for late-life depression, but clinicians must monitor for hyponatremia from SIADH, especially when combined with diuretics like hydrochlorothiazide or ACE inhibitors like lisinopril.
• Late-Life Depression AssessmentAdminister a validated tool like the PHQ-9 or Geriatric Depression Scale during routine clinical evaluations and initiate an SSRI if major depressive disorder is confirmed.

  • What it is: The systematic evaluation of depressive symptoms in adults aged 65 years and older using standardized tools validated for geriatric populations.
  • Why boards care: Test writers frequently present vignettes suggesting that mood or memory complaints in an older adult are merely normal aging or unassessable, testing whether the candidate recognizes valid screening tools.
  • A PHQ-9 score of 10 or greater indicates significant depressive symptoms requiring clinical evaluation; cognitive complaints secondary to depression (pseudodementia) improve with effective depression treatment.
  • Administer a validated tool like the PHQ-9 or Geriatric Depression Scale during routine clinical evaluations and initiate an SSRI if major depressive disorder is confirmed.
  • Monitor serum sodium levels after initiating an SSRI in an older adult, as hyponatremia from SIADH can precipitate acute delirium, confusion, and falls.
  • Selecting "no treatment needed" or "refer for neuropsychological testing" when an older adult screens positive for depression, or assuming mood symptoms are an inevitable part of normal aging.

  Board trap. Selecting "no treatment needed" or "refer for neuropsychological testing" when an older adult screens positive for depression, or assuming mood symptoms are an inevitable part of normal aging.

  Safety. Monitor serum sodium levels after initiating an SSRI in an older adult, as hyponatremia from SIADH can precipitate acute delirium, confusion, and falls.

• Depression in Older Adults vs. Normal AgingDo not confuse: Pathological mood disturbance with normal age-related psychosocial adjustments.

  • Do not confuse: Pathological mood disturbance with normal age-related psychosocial adjustments.
  • Think depression when: Patient exhibits anhedonia, vegetative signs, somatic complaints, uncharacteristic irritability, or pseudodementia.
  • Think normal aging when: Patient experiences temporary sadness related to specific life transitions without functional impairment or persistent vegetative symptoms.
  • Priority difference: Depression requires formal screening, safety assessment, and evidence-based treatment.
  • What boards are testing: Recognizing that advancing age alone does not cause depression.
• Major Depressive Disorder vs. Major Neurocognitive Disorder vs. DeliriumDo not confuse: The classic Three Ds of geriatric psychiatry.

  • Do not confuse: The classic Three Ds of geriatric psychiatry.
  • Think depression when: Onset is subacute, patient highlights cognitive deficits ("I cannot remember"), and mood symptoms precede cognitive complaints.
  • Think dementia when: Onset is insidious over months to years, patient conceals or minimizes memory loss, and impairment is progressive.
  • Think delirium when: Onset is acute over hours to days, consciousness fluctuates, and attention is severely impaired due to an underlying medical cause.
  • What boards are testing: Identifying reversible pseudodementia caused by depression versus primary neurocognitive decline or acute medical emergency.
• Fitzgerald Q2: Age as Depression Risk FactorAdvancing age itself is not an independent risk factor for major depression; assuming mood decline is a normal part of aging is a major diagnostic trap.

  • Advancing age itself is not an independent risk factor for major depression; assuming mood decline is a normal part of aging is a major diagnostic trap.
  • Standardized screening tools such as the PHQ-9 are fully validated in adults aged 65 and older across outpatient, hospital, and nursing home environments.
  • Up to 50% of patients diagnosed with major neurocognitive disorder suffer from co-occurring major depression.
  • Elderly white males aged 85 and older hold the highest suicide completion rate in the United States; 75% visited a primary care provider within one year and 45% within one month of death.
  • First-line pharmacotherapy for late-life depression is an SSRI; clinicians must monitor for hyponatremia, especially when combined with diuretics like hydrochlorothiazide or ACE inhibitors like lisinopril.
  • Avoid TCAs due to Beers Criteria warnings for severe anticholinergic toxicity, confusion, orthostatic hypotension, falls, and cardiac dysrhythmias.
• High-Yield SignpostsSSRIs are first-line for late-life depression. Initiate at half the standard adult starting dose, following the start low and go slow rule, but titrate to therapeutic goals. CBT and interpersonal therapy are first-line non-pharmacologic modalities.

  • Attributing depressive symptoms to normal aging or assuming older adults do not communicate suicidal intent. Older adults frequently express suicidal thoughts indirectly, through somatic complaints, or by giving away personal possessions.
  • SSRIs are first-line for late-life depression. Initiate at half the standard adult starting dose, following the start low and go slow rule, but titrate to therapeutic goals. CBT and interpersonal therapy are first-line non-pharmacologic modalities.

  Board trap. Attributing depressive symptoms to normal aging or assuming older adults do not communicate suicidal intent. Older adults frequently express suicidal thoughts indirectly, through somatic complaints, or by giving away personal possessions.

  Safety. SSRIs in older adults carry a significant risk of hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), particularly when co-prescribed with thiazide diuretics such as hydrochlorothiazide. Low serum sodium triggers delirium, confusion, and fall

• Differential Framework: The Geriatric TriadMajor depression: Onset is subacute over weeks to months. Mood is consistently depressed or anhedonic. Cognition demonstrates pseudodementia with poor effort on testing, where the patient frequently answers that they do not know.

  • Major depression: Onset is subacute over weeks to months. Mood is consistently depressed or anhedonic. Cognition demonstrates pseudodementia with poor effort on testing, where the patient frequently answers that they do not know.
  • Delirium: Onset is acute over hours to days with a fluctuating course. Primary deficit is in attention and awareness. It is caused by an underlying medical condition, infection like a UTI or pneumonia, or drug toxicity. It is reversible once the trigger is corrected.
  • Major neurocognitive disorder: Onset is insidious over months to years with progressive decline in executive function, memory, language, or social cognition. Consciousness and attention remain intact until late stages. Up to 50% have co-occurring depression.
• Key ClueA: Incorrect because age alone does not invalidate standardized screening tools.

  • A: Incorrect because age alone does not invalidate standardized screening tools.
  • C: Incorrect because screening tools remain valid in nursing homes and long-term care settings.
  • D: Incorrect because while severe cognitive impairment requires observational input, age over 65 does not render tools invalid.
• Fitzgerald Q3: Suicide CommunicationElderly white men aged 65 and older hold the highest completed suicide rate of any demographic group.

  • Elderly white men aged 65 and older hold the highest completed suicide rate of any demographic group.
  • Approximately 75% of older adults who die by suicide visited a primary care clinician within one year of death, and nearly 45% had healthcare contact within 30 days prior to their death.
  • Standardized depression screening instruments, including the PHQ-9, are fully validated and clinically effective for individuals over 65 years of age in outpatient and long-term care settings.
  • Advancing age itself is not an independent risk factor for developing major depressive disorder, despite the accumulation of psychosocial, functional, and physical losses.
  • Up to 50% of patients diagnosed with a major neurocognitive disorder also suffer from co-occurring major depressive disorder, illustrating the diagnostic overlap within the classic geriatric triad of depression, dementia, and delirium.
  • Pharmacotherapy in older adults must follow the start low and go slow principle while avoiding under-treatment, with SSRIs requiring vigilance for hyponatremia and tricyclic antidepressants avoided due to severe anticholinergic toxicity.
• Suicide Communication and Risk in Older AdultsWhen late-life major depressive disorder is diagnosed, SSRIs are first-line agents, but clinicians must monitor serum sodium due to the elevated risk of hyponatremia, especially when combined with hydrochlorothiazide or lisinopril.

  • Expressions of feeling like a burden, giving away belongings, or subtle statements about not being around much longer must be treated as active suicidal communication. Immediate safety evaluation, assessment of lethal means access, and crisis intervention are mandatory.
  • Do not select distractors stating that aging itself causes major depressive disorder or that screening tools like the PHQ-9 lose validity in older populations. Age alone is not an independent risk factor, and standardized screening tools remain valid.
  • When late-life major depressive disorder is diagnosed, SSRIs are first-line agents, but clinicians must monitor serum sodium due to the elevated risk of hyponatremia, especially when combined with hydrochlorothiazide or lisinopril.

  Board trap. Do not select distractors stating that aging itself causes major depressive disorder or that screening tools like the PHQ-9 lose validity in older populations. Age alone is not an independent risk factor, and standardized screening tools remain valid.

  Safety. Expressions of feeling like a burden, giving away belongings, or subtle statements about not being around much longer must be treated as active suicidal communication. Immediate safety evaluation, assessment of lethal means access, and crisis intervention are mandatory.

• Fitzgerald Q4: MNCD and Depression ComorbidityUp to 50 percent of individuals diagnosed with major neurocognitive disorder (MNCD or dementia) experience co-occurring depression.

  • Up to 50 percent of individuals diagnosed with major neurocognitive disorder (MNCD or dementia) experience co-occurring depression.
  • The core focus of geriatric psychiatry centers on the classic clinical triad known as the three Ds: depression, dementia, and delirium.
  • SSRIs such as sertraline are first-line treatment for depression in older adults with NCDs, and early treatment can delay progression to more advanced cognitive decline.
  • SSRIs carry a significant risk of hyponatremia in older adults, particularly when co-administered with diuretics or ACE inhibitors, increasing risks for falls and delirium.
  • Avoiding electroconvulsive therapy (ECT) in older adults is incorrect: ECT is safe and highly effective for severe or treatment-resistant depression in patients over 65 years of age.
  • Tricyclic antidepressants (TCAs) like amitriptyline should be avoided in older adults due to severe anticholinergic adverse effects, confusion, orthostatic hypotension, and delirium.

  Board trap. Avoiding electroconvulsive therapy (ECT) in older adults is incorrect: ECT is safe and highly effective for severe or treatment-resistant depression in patients over 65 years of age.

  Safety. SSRIs carry a significant risk of hyponatremia in older adults, particularly when co-administered with diuretics or ACE inhibitors, increasing risks for falls and delirium.

• First-Line Pharmacotherapy and Safety RulesTest-takers often incorrectly assume electroconvulsive therapy (ECT) is contraindicated in geriatric populations. ECT is a safe, highly effective modality for severe, psychotic, or treatment-resistant depression in patients over 65 years of age.

  • Test-takers often incorrectly assume electroconvulsive therapy (ECT) is contraindicated in geriatric populations. ECT is a safe, highly effective modality for severe, psychotic, or treatment-resistant depression in patients over 65 years of age.

  Board trap. Test-takers often incorrectly assume electroconvulsive therapy (ECT) is contraindicated in geriatric populations. ECT is a safe, highly effective modality for severe, psychotic, or treatment-resistant depression in patients over 65 years of age.

  Safety. SSRIs carry a well-documented risk of hyponatremia in older adults. This risk is heightened when SSRIs are combined with antihypertensive medications like hydrochlorothiazide or lisinopril. Serum sodium levels must be monitored because hyponatremia directly precipitates delirium,

• B) FalseA: True is incorrect because advancing age does not invalidate standardized depression screening instruments.

  • A: True is incorrect because advancing age does not invalidate standardized depression screening instruments.
• Fitzgerald Q10: Initial Diagnostic TestsSudden onset mental status changes over hours to days define delirium, which requires an urgent medical workup rather than psychiatric labeling.

  • Sudden onset mental status changes over hours to days define delirium, which requires an urgent medical workup rather than psychiatric labeling.
  • First-line laboratory evaluation for acute confusion includes serum glucose, urinalysis, complete blood count, comprehensive metabolic panel, liver function tests, and thyroid stimulating hormone.
  • Urinary tract infection and acute metabolic derangements like hyponatremia or hypoglycemia represent the most frequent reversible triggers for delirium in adults over 65 years of age.
  • Chronic dementia evaluation requires checking vitamin B12 and folate levels, adding homocysteine or methylmalonic acid if B12 is low-normal.
  • Neuroimaging with CT or MRI is indicated for structural workup in neurocognitive disorders, but basic laboratory studies and electrocardiogram precede neuroimaging when evaluating acute mental status changes.
  • HIV testing and VDRL are part of comprehensive dementia evaluations, but they are not essential immediate first-line tests for acute, sudden-onset confusion.
• First-line Diagnostic Workup for Acute ConfusionWhen an older adult presents with acute mental status change, the initial priority is ruling out acute, life-threatening medical conditions.

  • When an older adult presents with acute mental status change, the initial priority is ruling out acute, life-threatening medical conditions.
  • First-line laboratory testing focuses on rapid, high-yield metabolic and infectious screening.
  • Safety alert: Sudden confusion in an older adult is **delirium** until proven otherwise.
  • Failing to identify underlying medical causes like sepsis or severe hypoglycemia can lead to rapid decline or death.

  Board trap. Do not jump to ordering a head CT scan or psychotropic medication before obtaining basic blood and urine laboratory tests. Non-invasive labs and an electrocardiogram take priority over immediate neuroimaging unless trauma or focal neurological signs are present.

  Safety. Sudden confusion in an older adult is delirium until proven otherwise. Failing to identify underlying medical causes like sepsis or severe hypoglycemia can lead to rapid decline or death.

• Laboratory Comparison: Acute Delirium vs. Chronic Neurocognitive WorkupAcute workup focuses on serum glucose, urinalysis, electrolytes, liver function tests, complete blood count, and arterial oxygenation or pulse oximetry to detect acute infection, hypoxia, or organ failure.

  • Acute workup focuses on serum glucose, urinalysis, electrolytes, liver function tests, complete blood count, and arterial oxygenation or pulse oximetry to detect acute infection, hypoxia, or organ failure.
  • Chronic workup for major neurocognitive disorder adds thyroid stimulating hormone, vitamin B12, folate, RPR or VDRL, and HIV screening to identify metabolic, nutritional, or chronic infectious causes of cognitive decline.
• RationaleWhy A is incorrect: Checking a serum glucose level is essential to immediately rule out hypoglycemia or severe hyperglycemia as a cause of acute delirium.

  • Why A is incorrect: Checking a serum glucose level is essential to immediately rule out hypoglycemia or severe hyperglycemia as a cause of acute delirium.
  • Why B is incorrect: Obtaining a urinalysis is an essential initial test to rule out a urinary tract infection, which is one of the most common infectious triggers of delirium in older adults.
  • Why C is incorrect: Checking liver function tests is essential during initial assessment to rule out hepatic dysfunction or hepatic encephalopathy contributing to acute cognitive changes.
• Mild vs Major Neurocognitive DisorderAcquired Cognitive Decline: Neurocognitive disorders (NCDs) represent a decline from a previously established level of functioning across one or more of the six cognitive domains, distinct from neurodevelopmental conditions.

  • Acquired Cognitive Decline: Neurocognitive disorders (NCDs) represent a decline from a previously established level of functioning across one or more of the six cognitive domains, distinct from neurodevelopmental conditions.
  • Mild NCD Diagnostic Threshold: Characterized by modest cognitive decline in at least one cognitive domain. Independence in daily activities is preserved; instrumental activities of daily living (IADLs) require greater effort or compensatory strategies, but no physical assistance.
  • The Six Cognitive Domains: Complex attention, executive function, learning and memory, language, perceptual-motor, and social cognition.
  • Black Box Warning: Antipsychotics used in elderly patients with NCD-related psychosis carry a Boxed Warning for a 1.6 to 1.7 times increased risk of death, primarily due to cardiovascular events (heart failure, sudden death) or infections (pneumonia).
  • Geriatric Triad and Co-occurring Depression: Up to 50% of patients with Major NCD experience co-occurring major depression. Screening and treating depression or anxiety with SSRIs in Mild NCD is essential and can delay progression to advanced NCD.
  • Tricyclic Antidepressant Avoidance: Avoid tricyclic antidepressants (TCAs) in older adults due to severe anticholinergic adverse effects including dry mouth, constipation, blurred vision, urinary retention, confusion, delirium, orthostatic hypotension, and falls.
• Clinical Trajectory and Delirium DynamicsDelirium Acceleration: Episodes of delirium significantly accelerate the cognitive decline and progression of Major NCD. Preventing and treating delirium early is a priority.

  • Delirium Acceleration: Episodes of delirium significantly accelerate the cognitive decline and progression of Major NCD. Preventing and treating delirium early is a priority.
  • Recurrent Delirium as a Clue: Multiple delirium episodes in an older adult often serve as an underlying signal of an undiagnosed Major NCD.
  • Reversible Causes: Reversible causes of cognitive impairment (normal pressure hydrocephalus, subdural hematoma, B12 deficiency, thyroid disease, metabolic dysregulation) account for only 2% to 5% of cases. Established Major NCDs are typically progressive and irreversible.
• The Six Cognitive Domains: Mild vs Major Clinical Presentations1. Learning and Memory.

  • 1. Learning and Memory.
  • Domain Focus: Immediate memory, recent memory, cued recall, and long-term memory.
  • Mild NCD Presentation: Difficulty recalling recent events, increased reliance on list-making or calendars, losing track of whether bills have already been paid.
  • Major NCD Presentation: Repeats questions or statements within the same conversation, requires frequent step-by-step reminders to orient to tasks (such as putting toothpaste on a toothbrush or remembering that a meal is taking place).
  • 2. Executive Function.
  • Domain Focus: Planning, decision-making, working memory, responding to feedback, mental flexibility, and behavioral inhibition.
• First-LineFirst-line for Mild NCD with mood symptoms: Screen for depression using validated tools like the PHQ-9 and initiate an SSRI. Treating depression or anxiety can delay progression to advanced NCD.

  • First-line for Mild NCD with mood symptoms: Screen for depression using validated tools like the PHQ-9 and initiate an SSRI. Treating depression or anxiety can delay progression to advanced NCD.
  • First-line for mild to moderate Alzheimer's disease: Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine).
  • First-line for moderate to severe Alzheimer's disease: NMDA receptor antagonists (memantine) added to cholinesterase inhibitors.
  • First-line for behavioral and neuropsychiatric symptoms of NCD: Non-pharmacological strategies including environmental modifications, redirection, structured routines, personalized music, and caregiver support.
• Board TrapThe Baseline Fallacy: Assuming cholinesterase inhibitors restore a patient's cognition back to pre-disease baseline. Boards test that these drugs offer modest, temporary slowing of decline, not a cure or baseline restoration.

  • The Baseline Fallacy: Assuming cholinesterase inhibitors restore a patient's cognition back to pre-disease baseline. Boards test that these drugs offer modest, temporary slowing of decline, not a cure or baseline restoration.
  • The Premature Prescribing Trap: Reaching for second-generation antipsychotics to manage wandering, mild irritability, or vocalizations. Antipsychotics do not improve wandering or cognition and are reserved exclusively for severe agitation or immediate physical safety threats.
  • Age as Depression Cause: Assuming advanced age is an independent risk factor for depression. Age itself is not a risk factor; psychosocial and physical losses drive geriatric depression.
  • Routine Prescribing for Mild NCD: Starting cholinesterase inhibitors routinely in Mild NCD. They are not indicated or recommended for Mild NCD.
• Table: Neurocognitive Disorders FrameworkMajor neurocognitive disorder requires significant cognitive decline that interferes with independence in daily activities, requiring assistance with instrumental activities of daily living like managing finances or medications.

  • Major neurocognitive disorder requires significant cognitive decline that interferes with independence in daily activities, requiring assistance with instrumental activities of daily living like managing finances or medications.
  • Mild neurocognitive disorder involves modest cognitive decline where instrumental activities of daily living remain preserved, though greater effort or compensatory strategies like calendars and lists are required.
  • Delirium develops abruptly over hours to days with fluctuating attention and awareness, and repeated delirium episodes accelerate the underlying progression of major neurocognitive disorder.
  • Up to 50 percent of individuals diagnosed with a major neurocognitive disorder also suffer from co-occurring major depression, forming the classic geriatric triad of depression, dementia, and delirium.
  • Antipsychotic medications carry an FDA boxed warning for a 1.6 to 1.7 times increased risk of death in older adults with dementia-related psychosis, primarily due to cardiovascular events or pneumonia.
  • Cholinesterase inhibitors like donepezil, rivastigmine, and galantamine demonstrate the most clinical benefit during the mild to moderate stage of Alzheimer's disease.
• Neurocognitive Disorders FrameworkConduct a complete clinical history with the patient and a knowledgeable informant, assess baseline functional capabilities across daily activities, and obtain standardized neuropsychological testing to confirm cognitive decline before formulating a long-term care plan.

  • Conduct a complete clinical history with the patient and a knowledgeable informant, assess baseline functional capabilities across daily activities, and obtain standardized neuropsychological testing to confirm cognitive decline before formulating a long-term care plan.

  Board trap. Do not confuse mild neurocognitive disorder with major neurocognitive disorder based on symptom presence alone. The board exam tests whether the patient can still live independently. If instrumental activities of daily living are preserved, the diagnosis is mild NCD regardless of

  Safety. Recurrent delirium episodes cause irreversible neural damage and accelerate dementia progression. Always perform immediate medical workups to rule out reversible triggers like urinary tract infections, hyponatremia, or deliriogenic drugs before attributing confusion solely to dem

• Alzheimer’s Disease (AD)Alzheimer's disease is the most common cause of major neurocognitive disorder, characterized by gradual cognitive decline and average survival of 6 to 9 years after diagnosis.

  • Alzheimer's disease is the most common cause of major neurocognitive disorder, characterized by gradual cognitive decline and average survival of 6 to 9 years after diagnosis.
  • Core neuropathology consists of extracellular neuritic amyloid plaques and intracellular neurofibrillary tau tangles.
  • First-line pharmacotherapy for mild to moderate stages consists of acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine), while memantine is added for moderate to severe stages.
  • second-generation antipsychotics carry a boxed warning for a 1.6 to 1.7 times increased risk of death in elderly patients with NCD-related psychosis, primarily from cardiovascular events or pneumonia.
  • acetylcholinesterase inhibitors provide minor, temporary cognitive stabilization and do not restore patients to their pre-disease baseline.
  • Up to 50% of patients with major neurocognitive disorder have co-occurring depression, which should be evaluated and treated with an SSRI.

  Board trap. acetylcholinesterase inhibitors provide minor, temporary cognitive stabilization and do not restore patients to their pre-disease baseline.

  Safety. second-generation antipsychotics carry a boxed warning for a 1.6 to 1.7 times increased risk of death in elderly patients with NCD-related psychosis, primarily from cardiovascular events or pneumonia.

• Pharmacotherapy and Safety RulesFirst-line** treatment for mild to moderate **Alzheimer's disease** utilizes **acetylcholinesterase inhibitors** (**donepezil**, **rivastigmine**, **galantamine**).

  • First-line** treatment for mild to moderate **Alzheimer's disease** utilizes **acetylcholinesterase inhibitors** (**donepezil**, **rivastigmine**, **galantamine**).
  • These agents increase synaptic acetylcholine levels, producing modest, time-limited cognitive improvements.
  • Common side effects are cholinergic, primarily **nausea**, **vomiting**, and **diarrhea**.
  • For moderate to severe stages, the **NMDA receptor antagonist** **memantine** (**Namenda**) is added to regulate pathologically elevated glutamate activity.

  Board trap. Expecting psychotropic medications or cholinesterase inhibitors to return a patient to their pre-disease baseline. These medications slow progression modestly but do not reverse underlying neuronal loss. Additionally, jumping to prescribe an antipsychotic for minor non-emergent b

  Safety. Avoid medications with strong anticholinergic properties, such as tricyclic antidepressants or first-generation antihistamines like diphenhydramine, because they worsen cognitive impairment, induce urinary retention, and precipitate acute delirium. When treating co-occurring depr

• Which of the following is the least likely characteristic of **Alzheimer's disease**?A. Slowly developing impairment of cognitive function

  • A. Slowly developing impairment of cognitive function
  • B. Chronic condition without reversal
  • C. Perceptual disturbances including visual hallucinations early in the course
  • D. Progressive and irreversible course
  • Why the Other Choices Are Wrong:
  • A is incorrect because a gradual, slowly progressive decline in cognitive function over months to years is a cardinal diagnostic requirement for AD.
• Vascular DiseaseVascular neurocognitive disorder is the second most common cause of major neurocognitive disorder, frequently co-occurring with Alzheimer's disease as a mixed neurocognitive disorder.

  • Vascular neurocognitive disorder is the second most common cause of major neurocognitive disorder, frequently co-occurring with Alzheimer's disease as a mixed neurocognitive disorder.
  • Shortens average lifespan by approximately 3 years following diagnosis, compared to a 6 to 9 year average survival in Alzheimer's disease.
  • Onset is characterized by a sudden or step-wise decline following cerebrovascular events, TIAs, or small vessel ischemic disease, rather than the smooth insidious onset seen in Alzheimer's disease.
  • Initial cognitive deficits disproportionately affect complex attention, processing speed, and executive function, while short-term memory may remain relatively preserved early on.
  • Pathophysiology stems from cortical and subcortical vascular infarcts, lacunar lesions, and small vessel ischemic brain injury.
  • First-line intervention centers on aggressive management of cardiovascular risk factors, including blood pressure control, diabetes management, lipid lowering, and antiplatelet therapy such as aspirin.
• Core Features and Onset Pattern**Vascular neurocognitive disorder** represents the second most frequent cause of major neurocognitive impairment in older adults.

  • **Vascular neurocognitive disorder** represents the second most frequent cause of major neurocognitive impairment in older adults.
  • Unlike the slow, insidious progression of **Alzheimer's disease**, vascular cognitive decline frequently manifests with a sudden onset or a distinct step-wise trajectory following discrete cardiovascular or cerebrovascular events.
  • Patients often experience sudden drops in functional capacity interspersed with periods of stability.
  • **Board trap:** Exam items frequently attempt to mislead candidates by presenting a patient with cognitive decline and prompting for **Alzheimer's disease**.

  Board trap. Exam items frequently attempt to mislead candidates by presenting a patient with cognitive decline and prompting for Alzheimer's disease. Pay close attention to the timeline. If the vignette describes a step-wise drop in executive function following a stroke, transient ischemic a

• Pathophysiology and Vascular Risk FactorsCo-occurring delirium or post-stroke major depressive disorder occurs in a significant portion of vascular patients and can dramatically accelerate cognitive decline. Managing systemic vascular health is essential to prevent secondary ischemic events.

  • Co-occurring delirium or post-stroke major depressive disorder occurs in a significant portion of vascular patients and can dramatically accelerate cognitive decline. Managing systemic vascular health is essential to prevent secondary ischemic events.

  Safety. Co-occurring delirium or post-stroke major depressive disorder occurs in a significant portion of vascular patients and can dramatically accelerate cognitive decline. Managing systemic vascular health is essential to prevent secondary ischemic events.

• Diagnostic DifferentiationAlzheimer's disease: Insidious onset, smooth progressive decline, early short-term memory deficits, neurofibrillary tangles and amyloid plaques, average survival 6 to 9 years post-diagnosis.

  • Alzheimer's disease: Insidious onset, smooth progressive decline, early short-term memory deficits, neurofibrillary tangles and amyloid plaques, average survival 6 to 9 years post-diagnosis.
  • Vascular neurocognitive disorder: Sudden or step-wise decline, focal neurological deficits, early executive function and attention impairment, subcortical/cortical infarcts, shortens lifespan by 3 years.
  • Lewy body disease: Third most common subtype, early visual hallucinations, REM sleep behavior disorder, fluctuating cognition, severe parkinsonism, extreme neuroleptic sensitivity.
  • Frontotemporal neurocognitive disorder: Early behavioral disinhibition, apathy, loss of empathy, or primary progressive language breakdown with early relative preservation of memory.
• Pharmacologic and Non-Pharmacologic ManagementAggressive modification of cardiovascular risk factors is the primary clinical priority. This includes optimal control of hypertension, diabetes, and hyperlipidemia, alongside antiplatelet agents like aspirin and lifestyle interventions such as a Mediterranean heart-healthy diet

  • **First-line:** Aggressive modification of cardiovascular risk factors is the primary clinical priority.
  • This includes optimal control of hypertension, diabetes, and hyperlipidemia, alongside antiplatelet agents like **aspirin** and lifestyle interventions such as a Mediterranean heart-healthy diet and physical activity.
  • **SSRIs** are preferred for comorbid anxiety or post-stroke depression.
• Lewy Body Disease (LBD)Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) treat cognitive deficits and memory decline.

  • Lewy body disease is the third most common cause of major neurocognitive disorder, following Alzheimer's disease and vascular dementia.
  • Average age of diagnosis is 68 years old, with death occurring around 75 years old, progressing more rapidly than Alzheimer's disease.
  • Core diagnostic features include detailed spontaneous visual hallucinations, fluctuating cognition and alertness, REM sleep behavior disorder, and motor parkinsonism (bradykinesia, rigidity, postural instability).
  • Diagnostic timing rule: Motor parkinsonism presents within 1 year before or after the onset of cognitive decline.
  • Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) treat cognitive deficits and memory decline.
  • Extreme neuroleptic sensitivity exists. Traditional antipsychotics can precipitate severe extrapyramidal symptoms, rigidity, severe bradycardia, or fatal neuroleptic malignant syndrome.

  Board trap. Assuming early short-term memory loss is required for diagnosis. Short-term memory loss is a late feature in Lewy body disease, whereas visual hallucinations and sleep disturbances appear early.

  Safety. Extreme neuroleptic sensitivity exists. Traditional antipsychotics can precipitate severe extrapyramidal symptoms, rigidity, severe bradycardia, or fatal neuroleptic malignant syndrome.

• Lewy Body DiseaseWhat it is: A progressive major neurocognitive disorder caused by abnormal intraneuronal alpha-synuclein protein deposits called Lewy bodies in cortical and subcortical brain regions.

  • What it is: A progressive major neurocognitive disorder caused by abnormal intraneuronal alpha-synuclein protein deposits called Lewy bodies in cortical and subcortical brain regions.
  • Why boards care: It tests the ability to recognize non-memory early symptoms, differentiate diagnostic timelines, and avoid life-threatening psychotropic prescribing errors.
  • Typical board clue: An older adult presenting with vivid visual hallucinations, dream enactment during sleep, and new motor stiffness, or a patient who develops severe rigidity and bradycardia after receiving a low-dose antipsychotic.
  • First-line approach: Rule out medical causes of delirium. Initiate acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) for cognitive support.
  • When the answer changes: If severe agitation or psychosis poses an immediate safety risk, consider low-dose quetiapine with extreme caution due to neuroleptic sensitivity.
  • Severe neuroleptic sensitivity can cause acute extrapyramidal collapse, catatonia, or neuroleptic malignant syndrome. All antipsychotics carry a boxed warning for increased mortality in dementia-related psychosis.

  Safety. Severe neuroleptic sensitivity can cause acute extrapyramidal collapse, catatonia, or neuroleptic malignant syndrome. All antipsychotics carry a boxed warning for increased mortality in dementia-related psychosis.

• Lewy Body Disease vs. Alzheimer's DiseaseDo not confuse: Primary early symptoms and psychotropic tolerance differ significantly between these conditions.

  • Do not confuse: Primary early symptoms and psychotropic tolerance differ significantly between these conditions.
  • Think Lewy Body Disease when: Patient presents with early visual hallucinations, REM sleep behavior disorder, fluctuating alertness, motor parkinsonism, and severe neuroleptic sensitivity. Short-term memory loss is late.
  • Think Alzheimer's Disease when: Patient presents with early short-term memory loss and insidious cognitive decline without early parkinsonism or early visual hallucinations.
  • Priority difference: Avoid traditional antipsychotics in Lewy Body Disease due to life-threatening sensitivity risks.
  • What boards are really testing: Ability to recognize non-memory early features and avoid unsafe antipsychotic prescribing.
  • Classic distractor: Ordering haloperidol or potent D2 blockers for hallucinations in an older adult with unrecognized Lewy Body Disease.
• Lewy Body Disease vs. Parkinson's Disease DementiaDo not confuse: The chronological relationship between motor and cognitive symptom onset determines the diagnosis.

  • Do not confuse: The chronological relationship between motor and cognitive symptom onset determines the diagnosis.
  • Think Lewy Body Disease when: Cognitive decline occurs concurrently with parkinsonism or within 1 year of motor symptom onset.
  • Think Parkinson's Disease Dementia when: Well-established Parkinson's disease with motor symptoms exists for more than 1 year before cognitive decline develops.
  • Priority difference: Diagnostic classification rests strictly on the 1-year timeline threshold.
  • What boards are really testing: Precision with diagnostic timeframes in movement-related neurocognitive disorders.
  • Classic distractor: Diagnosing Parkinson's disease dementia when cognitive symptoms precede or occur simultaneously with motor signs.
• Common Board TrapsTrap: Prescribing typical antipsychotics or potent D2 blockers for visual hallucinations in Lewy body disease.

  • Trap: Prescribing typical antipsychotics or potent D2 blockers for visual hallucinations in Lewy body disease.
  • Why it looks right: Hallucinations are distressing and traditionally managed with antipsychotics.
  • Why it is wrong: Lewy body disease involves extreme neuroleptic sensitivity, leading to severe rigidity, catatonia, or fatal neuroleptic malignant syndrome.
  • Board rule to remember: Avoid traditional antipsychotics in Lewy body disease; consider low-dose quetiapine only if severe safety risks exist.
  • Trap: Expecting short-term memory loss as the initial requirement to diagnose Lewy body disease.
  • Why it looks right: Short-term memory loss is the classic early finding in Alzheimer's disease.
• DetailsLewy body disease stems from intraneuronal alpha-synuclein protein accumulations (Lewy bodies) distributed across subcortical and cortical structures, disrupting central cholinergic and dopaminergic pathways.

  • Lewy body disease stems from intraneuronal alpha-synuclein protein accumulations (Lewy bodies) distributed across subcortical and cortical structures, disrupting central cholinergic and dopaminergic pathways.
• Which of the following is the least likely characteristic of Alzheimer's disease?A. Slowly developing impairment of cognitive function

  • A. Slowly developing impairment of cognitive function
  • B. Chronic condition without reversal
  • C. Perceptual disturbances including hallucinations
  • D. Progressive and irreversible
• Which of the following is least likely to be noted in the person with Lewy body disease?A. Short-term memory loss

  • A. Short-term memory loss
  • B. Bradykinesia and rigidity
  • C. Visual hallucinations
  • D. REM sleep behavior disorder
• Active Recall Checkpoints1. What is the prevalence rank of Lewy body disease among major neurocognitive disorders?

  • 1. What is the prevalence rank of Lewy body disease among major neurocognitive disorders?
  • 2. What is the defining diagnostic timeline distinguishing Lewy body disease from Parkinson's disease dementia?
  • 3. Which sleep disorder featuring dream enactment frequently precedes cognitive decline in Lewy body disease?
  • 4. What dangerous adverse reaction can occur if a patient with Lewy body disease receives a traditional antipsychotic?
  • 5. Which second-generation antipsychotic is best studied and preferred at low doses when severe agitation occurs in Lewy body disease?
  • 6. What is the mean age of diagnosis and mean age of death for Lewy body disease?
• Frontotemporal Disease (FTD/Pick’s)Peak age of onset: FTD typically presents at a younger age than Alzheimer's disease, with onset occurring between ages 40 and 65 (mean age in the 50s to 60s).

  • Peak age of onset: FTD typically presents at a younger age than Alzheimer's disease, with onset occurring between ages 40 and 65 (mean age in the 50s to 60s).
  • First-line pharmacotherapy: Selective serotonin reuptake inhibitors (SSRIs) like sertraline or trazodone are used to manage behavioral disinhibition, impulsivity, hyperorality, and compulsive symptoms.
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine are not indicated for FTD and can exacerbate agitation and behavioral dysregulation.

  Safety. Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine are not indicated for FTD and can exacerbate agitation and behavioral dysregulation.

• High-Yield Concept: Frontotemporal Disease (FTD / Pick's)What it is: A major neurocognitive disorder caused by progressive focal atrophy of the frontal and temporal lobes, resulting in early social disinhibition, apathy, loss of empathy, hyperorality, compulsive behaviors, or primary progressive aphasia.

  • What it is: A major neurocognitive disorder caused by progressive focal atrophy of the frontal and temporal lobes, resulting in early social disinhibition, apathy, loss of empathy, hyperorality, compulsive behaviors, or primary progressive aphasia.
  • Why boards care: Exam questions evaluate your ability to distinguish FTD from Alzheimer's disease based on younger age of onset (40s to 60s) and early clinical domain impairment (behavior, personality, and executive function rather than short-term memory loss).
  • Must-know features:
  • Behavioral variant: marked loss of social decorum, apathy, loss of sympathy or empathy, hyperorality (dietary changes, compulsive eating), and repetitive, stereotypic behaviors.
  • Language variant: progressive difficulty with word finding, naming, speech fluency, or word comprehension.
  • Relative preservation of short-term memory and visuospatial orientation during early stages.

  Board trap. Misdiagnosing early FTD as late-onset mania, major depression, or a primary personality disorder due to dramatic behavioral disinhibition occurring without early memory impairment.

  Safety. Avoid prescribing cholinesterase inhibitors or memantine, as they lack efficacy in FTD and frequently worsen neuropsychiatric symptoms and agitation.

• Frontotemporal Disease (FTD) vs. Alzheimer's Disease (AD)Think FTD when: Patient presents at a younger age (40s to 60s) with early behavioral disinhibition, loss of empathy, apathy, or language difficulty while short-term memory remains intact early on.

  • Think FTD when: Patient presents at a younger age (40s to 60s) with early behavioral disinhibition, loss of empathy, apathy, or language difficulty while short-term memory remains intact early on.
  • Think AD when: Patient presents in older age with insidious, progressive short-term memory loss, learning deficits, and temporal/hippocampal atrophy.
  • Treatment difference: AD is managed with cholinesterase inhibitors (donepezil, rivastigmine, galantamine) for mild to moderate stages and memantine for moderate to severe stages; FTD avoids these agents and utilizes SSRIs for behavioral symptoms.
• Frontotemporal Disease (FTD) vs. Dementia with Lewy Bodies (DLB)Think FTD when: Primary presentation centers on frontal social disinhibition, compulsive behaviors, or progressive aphasia without early motor parkinsonism or visual hallucinations.

  • Think FTD when: Primary presentation centers on frontal social disinhibition, compulsive behaviors, or progressive aphasia without early motor parkinsonism or visual hallucinations.
  • Think DLB when: Patient presents with recurrent visual hallucinations, fluctuating alertness, REM sleep behavior disorder, and parkinsonian motor signs (rigidity, tremors, falls) occurring within 1 year of cognitive decline.
  • Safety difference: DLB carries extreme neuroleptic sensitivity where low-dose antipsychotics can trigger fatal rigidity or neuroleptic malignant syndrome; FTD avoids cholinesterase inhibitors.
• Frontotemporal Disease (FTD) vs. Vascular Neurocognitive DisorderThink FTD when: Gradual, progressive neurodegenerative frontal and temporal lobe atrophy leads to insidious social conduct or language breakdown.

  • Think FTD when: Gradual, progressive neurodegenerative frontal and temporal lobe atrophy leads to insidious social conduct or language breakdown.
  • Think Vascular NCD when: Cognitive decline occurs in a stepwise or abrupt pattern following cardiovascular events or strokes, accompanied by focal neurological deficits and cardiovascular risk factors.
• Huntington’s DiseaseSubcortical classification: Huntington's disease is an autosomal dominant specifier of major neurocognitive disorder classified as a subcortical dementia, defined by motor dysfunction like chorea while language and insight remain preserved until late stages.

  • Subcortical classification: Huntington's disease is an autosomal dominant specifier of major neurocognitive disorder classified as a subcortical dementia, defined by motor dysfunction like chorea while language and insight remain preserved until late stages.
  • Genetic screening timeline: Genetic testing is indicated for early-onset neurocognitive presentations occurring before age 65, which accounts for fewer than 5 percent of typical dementia cases.
  • High psychiatric comorbidity: Up to 50 percent of individuals with major neurocognitive disorder suffer from co-occurring depression, and 98 percent exhibit neuropsychiatric symptoms over their clinical course.
  • First-line depression care: First-line pharmacotherapy for co-occurring depressive symptoms in neurocognitive disorders is an SSRI such as sertraline.
  • Safety alert on hyponatremia: SSRIs carry a safety alert for hyponatremia in older adults, especially when combined with diuretics like hydrochlorothiazide, elevating the risk for delirium and falls.
  • Safety alert on antipsychotic mortality: Antipsychotics carry an FDA boxed warning for a 1.6 to 1.7 times increased risk of mortality in older adults with NCD-related psychosis, primarily from cardiovascular events or pneumonia.
• Clinical Features and Subcortical DistinctionHuntington's disease** is an inherited, **autosomal dominant** neurodegenerative disorder that serves as a diagnostic specifier for **major neurocognitive disorder**.

  • Huntington's disease** is an inherited, **autosomal dominant** neurodegenerative disorder that serves as a diagnostic specifier for **major neurocognitive disorder**.
  • It is classified as a subcortical dementia because the primary neuropathology targets subcortical structures like the basal ganglia.
  • The hallmark physical presentation is **chorea**, characterized by involuntary, dance-like, irregular movements.
  • A critical diagnostic distinction tested on board exams is that cortical functions such as **language** and **insight** remain relatively preserved until the late stages of **Huntington's disease**.

  Board trap. Do not confuse cortical dementias with subcortical dementias. Think Alzheimer's disease when early memory loss, aphasia, and executive dysfunction precede motor signs. Think Huntington's disease when prominent motor symptoms like chorea and early personality changes occur while l

• Neuropsychiatric Management and SafetyFirst-line management for co-occurring mood symptoms is a selective serotonin reuptake inhibitor such as sertraline. Standardized depression screening tools like the PHQ-9 remain valid and reliable in older adults over age 65.

  • First-line management for co-occurring mood symptoms is a selective serotonin reuptake inhibitor such as sertraline. Standardized depression screening tools like the PHQ-9 remain valid and reliable in older adults over age 65.
  • Monitor older patients started on an SSRI for hyponatremia. Combining SSRIs with antihypertensives like lisinopril or diuretics like hydrochlorothiazide increases sodium loss, which can precipitate acute delirium and severe falls.
  • All antipsychotics carry a black box warning when used in older adults with neurocognitive disorders due to a 1.6 to 1.7 times higher mortality rate compared to placebo. Deaths are most often caused by heart failure, sudden cardiac death, or pneumonia.
  • Avoid prescribing antipsychotics for routine behavioral disturbances, wandering, or mild agitation. Antipsychotics do not improve wandering, functional status, or overall quality of life. Reserve them strictly for severe agitation or active safety hazards.

  Board trap. Avoid prescribing antipsychotics for routine behavioral disturbances, wandering, or mild agitation. Antipsychotics do not improve wandering, functional status, or overall quality of life. Reserve them strictly for severe agitation or active safety hazards.

  Safety. Monitor older patients started on an SSRI for hyponatremia. Combining SSRIs with antihypertensives like lisinopril or diuretics like hydrochlorothiazide increases sodium loss, which can precipitate acute delirium and severe falls.

• Antipsychotic Treatment Limits98% of patients with major neurocognitive disorders experience neuropsychiatric symptoms during their illness, driving severe caregiver burden and early nursing home placement.

  • 98% of patients with major neurocognitive disorders experience neuropsychiatric symptoms during their illness, driving severe caregiver burden and early nursing home placement.
  • Antipsychotic indications are strictly limited to severe, dangerous agitation or active physical safety threats, never for wandering, uncooperativeness, or routine insomnia.
  • Boxed Warning mortality risk demonstrates a 1.6 to 1.7 times increased mortality rate in elderly patients with neurocognitive disorder related psychosis treated with antipsychotics compared to placebo across 17 controlled trials.
  • Primary mortality causes linked to antipsychotic use in older adults are cardiovascular events such as heart failure or sudden cardiac death, and respiratory infections such as aspiration pneumonia.
  • Brexpiprazole holds an FDA indication for agitation associated with dementia due to Alzheimer's disease at low doses, but it still carries the full FDA Boxed Warning for increased elderly mortality.
  • Off-label SGA choices like low-dose risperidone, quetiapine, or olanzapine carry elevated risks of cerebrovascular accidents and ischemic stroke.
• High-Yield Clinical Concepts and LimitsNon-pharmacological interventions are the mandatory first step for managing mild to moderate neuropsychiatric symptoms in older adults.

  • Non-Pharmacological First-Line Strategy
  • Non-pharmacological interventions are the mandatory first step for managing mild to moderate neuropsychiatric symptoms in older adults.
  • Clinical actions: Identify underlying physical or environmental triggers, re-establish structured daily routines, utilize redirection, offer calm reassurance, and implement home safety modifications.
  • Antipsychotics do not improve cognition, functional capacity, wandering, or overall quality of life, and they must never be prescribed as a substitute for behavioral or environmental management.
  • FDA Boxed Warning and Mortality Parameters
  • All first-generation and second-generation antipsychotics carry an FDA Boxed Warning regarding increased mortality when administered to elderly patients with neurocognitive disorder related psychosis.

  Board trap. Prescribing an antipsychotic for minor irritability, verbal disruption, or sleep disturbance is a classic exam error. Use SSRIs like sertraline for mood or anxiety symptoms and cholinesterase inhibitors like donepezil for cognitive stabilization.

  Safety. Antipsychotics do not improve cognition, functional capacity, wandering, or overall quality of life, and they must never be prescribed as a substitute for behavioral or environmental management.

• C) Frontotemporal neurocognitive disorderQuick Answer: D. Lewy body disease presents with extreme neuroleptic sensitivity to antipsychotics.

  • Quick Answer: D. Lewy body disease presents with extreme neuroleptic sensitivity to antipsychotics.
  • Key Clue: Severe extrapyramidal symptoms, rigidity, and bradycardia following a low dose SGA.
  • Best Answer: D. Lewy body disease.
  • Why It Is Correct: Lewy body disease is characterized by extreme neuroleptic sensitivity. Administering even low-dose second-generation antipsychotics can trigger severe parkinsonism, rigidity, profound bradycardia, or neuroleptic malignant syndrome.
  • Why the Other Choices Are Wrong:
  • A: Alzheimer's disease typically presents with insidious memory loss and does not exhibit acute severe extrapyramidal collapse from low-dose SGAs.
• Behavioral Management and SleepNeuropsychiatric symptoms (NPS) occur in 98% of patients with major neurocognitive disorders (NCDs), accelerating disease progression, driving caregiver burnout, and precipitating early nursing home placement.

  • Neuropsychiatric symptoms (NPS) occur in 98% of patients with major neurocognitive disorders (NCDs), accelerating disease progression, driving caregiver burnout, and precipitating early nursing home placement.
  • First-line treatment for behavioral disruptions and sleep alterations is always non-pharmacological, incorporating routine maintenance, environment modification, redirection, reassurance, and music therapy.
  • Pharmacotherapy for routine insomnia in major NCD is not indicated; sedatives like zolpidem elevate fall and fracture risks, while anticholinergics like diphenhydramine and benzodiazepines like diazepam precipitate acute delirium.
  • Antipsychotics carry an FDA boxed warning for older adults with NCD-related psychosis due to a 1.6 to 1.7 times increased risk of death, primarily from cardiovascular collapse or pneumonia.
  • Antipsychotics do not improve wandering, underlying cognition, physical functioning, or overall quality of life, and must be reserved strictly for severe agitation or immediate physical safety hazards.
  • Brexpiprazole is low-dose FDA-approved for Alzheimer's agitation, while low-dose quetiapine, risperidone, olanzapine, or haloperidol are used off-label with extreme caution.

  Board trap. Patients with Lewy body disease possess extreme neuroleptic sensitivity; administering even low-dose antipsychotics can trigger life-threatening rigidity, severe parkinsonism, and neuroleptic malignant syndrome.

  Safety. Antipsychotics carry an FDA boxed warning for older adults with NCD-related psychosis due to a 1.6 to 1.7 times increased risk of death, primarily from cardiovascular collapse or pneumonia.

• Categorization of Neuropsychiatric SymptomsAffective and motivational group: Presents as co-occurring depression, profound apathy, generalized anxiety, and emotional irritability, best managed initially with SSRIs like sertraline rather than sedatives.

  • Affective and motivational group: Presents as co-occurring depression, profound apathy, generalized anxiety, and emotional irritability, best managed initially with SSRIs like sertraline rather than sedatives.
  • Psychotic symptoms group: Encompasses persecutory delusions and visual or auditory hallucinations, requiring medical rule-outs before considering low-dose psychotropics.
  • Basic drive disturbances group: Features severe disruptions in sleep-wake cycles, diurnal fluctuation (sundowning), hyperorality or reduced feeding, and altered sexual behaviors.
  • Disinhibited behavior group: Involves wandering, repetitive vocalizations, pacing, and socially inappropriate actions stemming from frontal executive dysfunction.
• Non-Pharmacological Behavioral Interventions and Sleep ManagementFirst-line approach: Establish rigid daily routines, maintain consistent lighting to reduce evening sundowning, apply door alarms and stove shut-off timers for wandering, and utilize adult day care to alleviate caregiver burnout.

  • First-line approach: Establish rigid daily routines, maintain consistent lighting to reduce evening sundowning, apply door alarms and stove shut-off timers for wandering, and utilize adult day care to alleviate caregiver burnout.
  • Cognitive and sensory interventions: Implement reminiscence therapy, personalized music listening, non-confrontational communication, and immediate verbal reassurance during catastrophic outbursts.
  • Never prescribe sedatives, antihistamines, or long-acting benzodiazepines for routine nighttime sleep disturbances in dementia patients, as they impair gait and worsen cognitive confusion.
  • Assuming an angry outburst in a previously calm dementia patient requires immediate antipsychotics is a classic exam trap; always assess for underlying physical pain, urinary tract infections, routine disruptions, or re-triggered personal trauma first.

  Board trap. Assuming an angry outburst in a previously calm dementia patient requires immediate antipsychotics is a classic exam trap; always assess for underlying physical pain, urinary tract infections, routine disruptions, or re-triggered personal trauma first.

  Safety. Never prescribe sedatives, antihistamines, or long-acting benzodiazepines for routine nighttime sleep disturbances in dementia patients, as they impair gait and worsen cognitive confusion.

• Pharmacological Management and Black Box SafetyCholinesterase inhibitors: Donepezil, rivastigmine, and galantamine offer modest, time-limited stabilization of cognitive and behavioral symptoms in mild-to-moderate Alzheimer's disease, but they do not restore functioning to pre-disease baseline.

  • Cholinesterase inhibitors: Donepezil, rivastigmine, and galantamine offer modest, time-limited stabilization of cognitive and behavioral symptoms in mild-to-moderate Alzheimer's disease, but they do not restore functioning to pre-disease baseline.
  • NMDA receptor antagonists: Memantine modulates glutamate and provides clinical synergy when added to cholinesterase inhibitors in moderate-to-severe Alzheimer's dementia.
  • Antipsychotic prescribing rules: Low-dose brexpiprazole, quetiapine, or risperidone should be short-term emergency options for severe agitation, combativeness, or unmanageable safety risks only.
  • All typical and atypical antipsychotics double the risk of mortality in elderly patients with NCD-related psychosis, caused predominantly by sudden cardiac arrest, heart failure, or aspiration pneumonia.

  Safety. All typical and atypical antipsychotics double the risk of mortality in elderly patients with NCD-related psychosis, caused predominantly by sudden cardiac arrest, heart failure, or aspiration pneumonia.

• SSRI and TCA ConsiderationsStart low and go slow, but titrate to therapeutic goals to avoid the common clinical mistake of under-treating depression in older adults.

  • Start low and go slow, but titrate to therapeutic goals to avoid the common clinical mistake of under-treating depression in older adults.
  • SSRI hyponatremia risk: Selective serotonin reuptake inhibitors carry a significant risk of hyponatremia in older adults, particularly when combined with thiazide diuretics like hydrochlorothiazide or ACE inhibitors like lisinopril.
  • Hyponatremia outcomes: Low sodium levels set older adults up for acute delirium, gait instability, and falls.
  • TCA avoidance: Tricyclic antidepressants like amitriptyline must be avoided in older adults due to severe anticholinergic adverse effects, orthostatic hypotension, cardiac dysrhythmias, and fall risk.
  • Anticholinergic toxicity spectrum: Anticholinergic toxicity presents peripherally as dry mouth, constipation, and blurry vision, and centrally as agitation, anxiety, confusion, visual hallucinations, delirium, psychosis, seizures, and coma.
  • Pre-prescribing organ assessment: Baseline renal and hepatic function tests must be completed prior to initiating psychotropic pharmacotherapy due to age-related organ clearance changes.
• Detailed Clinical Teaching: SSRI and TCA ConsiderationsFirst-line pharmacotherapy for late-life depression requires starting SSRIs at reduced doses and slowly titrating upward to full therapeutic efficacy.

  • First-line pharmacotherapy for late-life depression requires starting SSRIs at reduced doses and slowly titrating upward to full therapeutic efficacy.
  • While SSRIs are generally preferred over older drug classes, the primary Safety alert for SSRIs in geriatric practice is drug-induced hyponatremia caused by SIADH.
  • Older adults frequently take co-prescribed cardiovascular medications like lisinopril or hydrochlorothiazide.
  • Combining an SSRI with a diuretic synergistically increases the risk of hyponatremia, leading to subtle cognitive changes, gait disturbances, falls, and acute delirium.

  Board trap. Test questions often present an older adult taking an SSRI and a diuretic who develops sudden unsteadiness or confusion. Candidates frequently select a primary neurocognitive workup, whereas the board is testing SSRI-induced hyponatremia and fluid/electrolyte imbalance.

  Safety. Renal and hepatic function must be evaluated prior to initiating any psychotropic agent in older adults because age-related organ decline slows drug metabolism and excretion. Additionally, electroconvulsive therapy (ECT) is safe and highly effective for elders over age 65 and sho

• Anticholinergic Toxicity SymptomsRule 1: Older adults require starting psychotropic medications at 25% to 50% of standard adult starting doses, titrating slowly while avoiding under-treatment of clinical illness.

  • Rule 1: Older adults require starting psychotropic medications at 25% to 50% of standard adult starting doses, titrating slowly while avoiding under-treatment of clinical illness.
  • Rule 2: Peripheral anticholinergic side effects present as the classic triad of dry mouth, constipation, and blurry vision.
  • Rule 3: Central anticholinergic toxicity produces severe neuropsychiatric disruption, including agitation, anxiety, confusion, visual hallucinations, delirium, psychosis, seizures, and coma.
  • Rule 4: Tricyclic antidepressants like amitriptyline and first-generation antihistamines like diphenhydramine carry severe anticholinergic and alpha-1 blockade risks, significantly increasing fall risk, orthostatic hypotension, and memory impairment.
  • Rule 5: Electroconvulsive therapy (ECT) remains a safe and highly effective modality for severe or treatment-resistant depression in adults over age 65 years.
  • Rule 6: Selective serotonin reuptake inhibitors (SSRIs) like sertraline are preferred over TCAs due to low anticholinergic activity, but require monitoring for hyponatremia, especially when combined with thiazide diuretics or ACE inhibitors.
• Pharmacological Considerations in Geriatric PrescribingThe foundational prescribing rule in older adults is to start low and go slow, but titrate to therapeutic targets to avoid under-treating psychiatric conditions. Baseline renal panel, hepatic enzymes, and electrolyte panels must be drawn prior to initiating psychotropics.

  • The foundational prescribing rule in older adults is to start low and go slow, but titrate to therapeutic targets to avoid under-treating psychiatric conditions. Baseline renal panel, hepatic enzymes, and electrolyte panels must be drawn prior to initiating psychotropics.

  Safety. Polypharmacy is a major geriatric syndrome. Combining multiple central nervous system active medications increases the risk of falls, delirium, and drug interactions. Over-the-counter sleep aids and cold remedies frequently contain strong anticholinergic compounds that patients o

• Anticholinergic Side Effects vs. Central ToxicityAnticholinergic agents block muscarinic acetylcholine receptors throughout the central and peripheral nervous systems.

  • Anticholinergic agents block muscarinic acetylcholine receptors throughout the central and peripheral nervous systems.
  • Additional peripheral signs include urinary retention and anhidrosis.
  • * **Central Anticholinergic Toxicity**: Central muscarinic receptor blockade in the brain severely impairs memory, attention, and executive function.
  • Toxic progression manifests as agitation, severe anxiety, confusion, frank visual or auditory hallucinations, acute delirium, psychosis, seizures, and coma.

  Board trap. Test writers often present an older adult taking diphenhydramine or amitriptyline who develops new-onset confusion and visual hallucinations. Students frequently fall into the trap of misdiagnosing this acute state as worsening dementia or late-onset schizophrenia, rather than re

• High-Risk Medication Classes and Beers CriteriaToxicity Drivers: Amitriptyline, imipramine, and doxepin possess potent anticholinergic, antihistaminic, and alpha-1 adrenergic blocking properties. They cause severe orthostatic hypotension, cardiac conduction delays, QTc prolongation, and cognitive decline.

  • Toxicity Drivers: Amitriptyline, imipramine, and doxepin possess potent anticholinergic, antihistaminic, and alpha-1 adrenergic blocking properties. They cause severe orthostatic hypotension, cardiac conduction delays, QTc prolongation, and cognitive decline.
  • First-Generation Antihistamines: Diphenhydramine and hydroxyzine readily cross the blood-brain barrier, causing profound central anticholinergic toxicity, sedation, motor incoordination, and fall-related fractures.
• Peripheral Anticholinergic Effects vs. Central Anticholinergic ToxicityPeripheral Effects:

  • Peripheral Effects:
  • Think: Classic physical mucosal and autonomic blockade triad.
  • Defining Features: Dry mouth, severe constipation, blurry vision, urinary hesitation or retention, and reduced sweating.
  • Clinical Urgency: Causes discomfort and physical complications like impaction or urinary tract infections, but is non-fatal if managed early.
  • Central Toxicity:
  • Think: Acute brain failure and neurocognitive emergency.
• Amitriptyline vs. Sertraline in Older AdultsThink: High-risk tricyclic antidepressant to avoid in geriatrics.

  • Think: High-risk tricyclic antidepressant to avoid in geriatrics.
  • Defining Features: Heavy anticholinergic burden, high orthostatic hypotension risk, QTc prolongation, and high delirium potential.
  • Board Reality: Incorrect choice for elderly depression due to Beers Criteria red flags.
  • Think: Preferred first-line geriatric antidepressant.
  • Defining Features: Negligible anticholinergic activity, minimal cardiac effect, and favorable safety profile.
  • Board Reality: Correct first-line choice, requiring routine monitoring of serum sodium levels for hyponatremia.
• Electroconvulsive Therapy (ECT) in AgingElectroconvulsive therapy (ECT) is a safe, rapid, and highly effective treatment modality for severe, delusional, or treatment-resistant major depressive disorder in older adults over age 65.

  • Electroconvulsive therapy (ECT) is a safe, rapid, and highly effective treatment modality for severe, delusional, or treatment-resistant major depressive disorder in older adults over age 65.
  • Advanced age alone is not a contraindication to ECT; age over 65 years is not a reason to avoid treatment when clinically indicated.
  • Pharmacotherapy in aging requires starting low and going slow, but escalating to effective therapeutic goals to prevent under-treating depression.
  • Baseline renal function and hepatic function must be evaluated prior to starting psychotropics due to age-related organ clearance changes in older adults.
  • High anticholinergic burden from tricyclic antidepressants (TCAs) like amitriptyline must be avoided in elders due to risks of orthostatic hypotension, cardiac dysrhythmias, urinary retention, and delirium.
  • Selective serotonin reuptake inhibitors (SSRIs) like sertraline carry a heightened risk of hyponatremia, particularly when combined with diuretics like hydrochlorothiazide or ACE inhibitors like lisinopril.
• Board Trap: Misconceptions Regarding ECT in the ElderlyBoard trap:** Exam items often attempt to trick candidates into believing that advanced age makes **ECT** too dangerous or contraindicated.

  • Board trap:** Exam items often attempt to trick candidates into believing that advanced age makes **ECT** too dangerous or contraindicated.

  Board trap. Exam items often attempt to trick candidates into believing that advanced age makes ECT too dangerous or contraindicated. Test writers expect you to recognize that ECT is well-tolerated in older adults and is often safer than exposing elderly patients to prolonged, ineffective tr

• Polypharmacy SyndromePolypharmacy is a recognized geriatric syndrome where taking multiple concurrent medications significantly increases drug-drug interactions, adverse effects, and cognitive impairment.

  • Polypharmacy is a recognized geriatric syndrome where taking multiple concurrent medications significantly increases drug-drug interactions, adverse effects, and cognitive impairment.
  • Geriatric prescribing follows the rule to start low and go slow, but clinicians must titrate to therapeutic targets to prevent under-treatment of conditions like major depression.
  • SSRIs like sertraline carry a high risk of hyponatremia, which is exacerbated when combined with diuretics such as hydrochlorothiazide or ACE inhibitors like lisinopril.
  • Tricyclic antidepressants like amitriptyline must be avoided in older adults due to severe anticholinergic effects, orthostatic hypotension, and cardiac dysrhythmias.
  • Sedative-hypnotics like zolpidem and long-acting benzodiazepines like diazepam double the risk of motor impairment, falls, hip fractures, and acute confusion.
  • All antipsychotics carry an FDA boxed warning in older adults with major neurocognitive disorders due to a 1.6 to 1.7 times increased risk of mortality, primarily from cardiovascular events or pneumonia.
• Polypharmacy and Pharmacokinetic Aging ChangesConduct a thorough medication reconciliation at every clinical visit, including over-the-counter agents, and check baseline renal and liver function labs before initiating psychotropics.

  • What it is: Polypharmacy is a major geriatric syndrome driven by multiple chronic prescriptions, over-the-counter supplements, and age-related changes in drug distribution and clearance.
  • Conduct a thorough medication reconciliation at every clinical visit, including over-the-counter agents, and check baseline renal and liver function labs before initiating psychotropics.
  • Age-related decreases in renal glomerular filtration rate and hepatic enzyme activity slow drug clearance, causing drug accumulation and toxicity at standard adult doses.
  • Clinicians often misinterpret medication side effects as new medical conditions, leading to prescribing cascades where additional drugs are added instead of discontinuing the offending agent.

  Board trap. Clinicians often misinterpret medication side effects as new medical conditions, leading to prescribing cascades where additional drugs are added instead of discontinuing the offending agent.

  Safety. Age-related decreases in renal glomerular filtration rate and hepatic enzyme activity slow drug clearance, causing drug accumulation and toxicity at standard adult doses.

• High-Risk Psychotropics and Beers CriteriaTricyclic Antidepressants: Drugs like amitriptyline are contraindicated in older adults due to intense anticholinergic side effects, severe postural hypotension, and dysrhythmias.

  • Tricyclic Antidepressants: Drugs like amitriptyline are contraindicated in older adults due to intense anticholinergic side effects, severe postural hypotension, and dysrhythmias.
  • Anticholinergic Toxicity: Central signs include agitation, anxiety, confusion, hallucinations, delirium, psychosis, seizures, and coma, accompanied by dry mouth, constipation, and urinary retention.
  • Sedative-Hypnotics and Benzodiazepines: Agents such as zolpidem, diazepam, and diphenhydramine increase the risk of falls, hip fractures, motor impairment, and acute delirium.
  • All first-generation and second-generation antipsychotics carry an FDA boxed warning in older adults with major neurocognitive disorders due to a 1.6 to 1.7 fold increase in mortality from heart failure, sudden death, or pneumonia.

  Safety. All first-generation and second-generation antipsychotics carry an FDA boxed warning in older adults with major neurocognitive disorders due to a 1.6 to 1.7 fold increase in mortality from heart failure, sudden death, or pneumonia.

• Hyponatremia and SSRI TherapyMeasure baseline serum sodium levels and monitor periodically when starting an SSRI, especially in patients taking hydrochlorothiazide or lisinopril.

  • What it is: SSRIs such as sertraline frequently cause syndrome of inappropriate antidiuretic hormone secretion and hyponatremia in older adults.
  • Measure baseline serum sodium levels and monitor periodically when starting an SSRI, especially in patients taking hydrochlorothiazide or lisinopril.
  • Hyponatremia presents insidiously as subtle lethargy, gait instability, confusion, or falls, which test-takers may incorrectly attribute solely to aging or dementia progression.

  Board trap. Hyponatremia presents insidiously as subtle lethargy, gait instability, confusion, or falls, which test-takers may incorrectly attribute solely to aging or dementia progression.

• Depression Management and InterventionsSelect SSRIs with minimal anticholinergic activity and favorable drug-interaction profiles, initiating therapy at low doses while actively titrating to therapeutic goals.

  • Select SSRIs with minimal anticholinergic activity and favorable drug-interaction profiles, initiating therapy at low doses while actively titrating to therapeutic goals.
  • Do not avoid ECT in elderly patients purely because of advanced age. ECT is proven safe, rapid, and highly effective for severe, melancholic, or psychotic depression in adults over age 65.

  Safety. Do not avoid ECT in elderly patients purely because of advanced age. ECT is proven safe, rapid, and highly effective for severe, melancholic, or psychotic depression in adults over age 65.

• Fitzgerald Q11: Depression Therapy SelectionElectroconvulsive therapy is safe, well tolerated, and highly effective for patients over 65 years of age who suffer from severe or treatment resistant major depressive disorder.

  • Electroconvulsive therapy is safe, well tolerated, and highly effective for patients over 65 years of age who suffer from severe or treatment resistant major depressive disorder.
  • Pharmacotherapy in older adults must follow the guideline to start low and go slow, but clinicians must actively titrate to therapeutic targets to avoid under treatment.
  • Baseline renal function and hepatic function panel testing must be completed prior to initiating psychotropic medications due to age related reductions in clearance.
  • Tricyclic antidepressants such as amitriptyline should be avoided in older adults due to severe risks of orthostatic hypotension, confusion, and falls.
  • Selective serotonin reuptake inhibitors like sertraline are first line for late life depression, but patients require monitoring for hyponatremia, especially when co prescribed with thiazide diuretics.
  • Anticholinergic toxicity in geriatric patients presents with dry mouth, constipation, blurry vision, urinary retention, delirium, hallucinations, seizures, and coma.
• Key SignpostsSSRIs such as sertraline are the preferred initial pharmacotherapy for depression in older adults due to minimal cardiotoxicity and favorable tolerability.

  • SSRIs such as sertraline are the preferred initial pharmacotherapy for depression in older adults due to minimal cardiotoxicity and favorable tolerability.
  • High anticholinergic burden from agents like amitriptyline or diphenhydramine increases the risk of delirium, urinary retention, severe constipation, orthostatic hypotension, and traumatic falls.

  Board trap. Selecting an answer that claims ECT is unsafe or contraindicated purely based on advanced age. Board questions frequently test the misconception that elderly patients cannot receive ECT, when in fact age over 65 years is a primary setting where ECT demonstrates exceptional effica

  Safety. High anticholinergic burden from agents like amitriptyline or diphenhydramine increases the risk of delirium, urinary retention, severe constipation, orthostatic hypotension, and traumatic falls.

• Suicide Risk Assessment FactorsHighest risk demographic: White males aged 65 years and older maintain the highest rate of completed suicide among all geriatric demographic groups.

  • Highest risk demographic: White males aged 65 years and older maintain the highest rate of completed suicide among all geriatric demographic groups.
  • Communication of suicidal intent: Most elderly individuals who commit suicide do communicate their intent prior to the act, frequently using indirect statements, discussing death, or giving away personal possessions.
  • Non-independent age factor: Advancing age itself is not an independent risk factor for major depressive disorder, though age-associated psychosocial losses, living alone, alcohol abuse, and spousal bereavement significantly increase suicide risk.
  • Essential inquiry topics: Diagnostic evaluations for suicide risk in older adults must specifically inquire about loneliness, worthlessness, and perceived burdensomeness to family or caregivers.
  • High comorbidity rate: Up to 50% of patients diagnosed with a major neurocognitive disorder also suffer from co-occurring major depressive disorder, compounding suicide risk and functional decline.
  • Validated screening tools: Standardized instruments like the PHQ-9 are valid, reliable, and recommended for screening depression and suicidal ideation in individuals over 65 years of age across community and long-term care settings.
• High-Yield Risk Factors and DemographicsDemographic risk: Elderly white males aged 65 and older represent the highest statistical risk for completed suicide.

  • Demographic risk: Elderly white males aged 65 and older represent the highest statistical risk for completed suicide.
  • Precipitating triggers: Major life disruptions, including the recent death of a spouse, new onset of living alone, severe chronic illness or pain, and alcohol abuse, serve as primary triggers.
  • Subjective feelings: High risk correlates strongly with persistent loneliness, feelings of worthlessness, and perceiving oneself as a burden to loved ones.
  • Assuming that suicidal ideation or depressive symptoms are a normal consequence of aging is a critical diagnostic error; late-life depression is pathological and requires immediate intervention.

  Board trap. Assuming that suicidal ideation or depressive symptoms are a normal consequence of aging is a critical diagnostic error; late-life depression is pathological and requires immediate intervention.

• Assessment and Clinical Screening ProtocolsFirst-line action: Administer a validated screening tool, such as the PHQ-9, to measure depressive severity and identify suicidal ideation.

  • First-line action: Administer a validated screening tool, such as the PHQ-9, to measure depressive severity and identify suicidal ideation.
  • Direct inquiry: Explicitly ask about passive thoughts of death, active suicidal intent, specific plans, timelines, and access to lethal means.
  • Behavioral indicators: Recognize warning signs such as sudden distribution of personal possessions, abrupt revisions to legal wills, or an unexpected period of calm following severe depression.
  • Directly assess for immediate access to firearms, stockpiled prescription medications, or other lethal household items.

  Safety. Directly assess for immediate access to firearms, stockpiled prescription medications, or other lethal household items.

• Differential Diagnostics and ComorbiditiesThe three Ds of geriatric psychiatry: Always differentiate and evaluate for depression, dementia (major neurocognitive disorder), and delirium.

  • The three Ds of geriatric psychiatry: Always differentiate and evaluate for depression, dementia (major neurocognitive disorder), and delirium.
  • Comorbidity: Recognize that up to 50% of patients with major neurocognitive disorder present with co-occurring depression.
  • Medical mimics: Rule out underlying physiological causes of depressive symptoms, including hypothyroidism, vitamin B12 deficiency, or medication adverse effects, prior to confirming a primary psychiatric diagnosis.
• Active Recall Questions1. Which specific demographic group among older adults has the highest rate of completed suicide?

  • 1. Which specific demographic group among older adults has the highest rate of completed suicide?
  • 2. Is advancing age independently classified as a direct risk factor for major depressive disorder?
  • 3. What percentage of patients with a major neurocognitive disorder also experience co-occurring depression?
  • 4. What three specific subjective feelings must clinicians directly inquire about during a geriatric suicide risk assessment?
  • 5. How do older adults commonly express suicidal intent prior to a suicide attempt?
• Screening Tools for Older AdultsGeriatric Depression Scale (GDS): A 30-item self-report questionnaire or 15-item short version specifically validated for detecting depression and tracking treatment response in older adults.

  • Geriatric Depression Scale (GDS): A 30-item self-report questionnaire or 15-item short version specifically validated for detecting depression and tracking treatment response in older adults.
  • PHQ-9 Validation in Late Life: Validated for use in adults 65 years and older, including nursing home residents, with scores of 10 or higher indicating moderate depression.
  • Suicide Communication Myth: Most elderly individuals who commit suicide communicate their intent prior to the act through direct statements, indirect comments, or giving away personal belongings.
  • Demographic Vulnerability: Elderly white males age 65 and older represent the population with the highest completed suicide rate among older adults.
  • Age as an Independent Risk Factor: Advancing age itself is not an independent risk factor for major depression, although physical losses and medical comorbidities increase overall vulnerability.
  • Co-occurring Depression in Dementia: Up to 50% of patients with major neurocognitive disorders suffer from co-occurring major depressive disorder.
• High-Yield Signposts and Exam RulesSelective serotonin reuptake inhibitors (SSRIs) such as sertraline or escitalopram are first-line pharmacotherapy for late-life major depression, initiated at half the typical starting dose.

  • Older adults expressing passive death wishes, feelings of burdensomeness, or giving away personal items require immediate suicide risk assessment, environmental safety planning, and lethal means restriction.
  • Believing that depression is a normal physiological part of aging or that suicidal elderly patients do not talk about their plans. On the exam, both assumptions are false.
  • Selective serotonin reuptake inhibitors (SSRIs) such as sertraline or escitalopram are first-line pharmacotherapy for late-life major depression, initiated at half the typical starting dose.

  Board trap. Believing that depression is a normal physiological part of aging or that suicidal elderly patients do not talk about their plans. On the exam, both assumptions are false.

  Safety. Older adults expressing passive death wishes, feelings of burdensomeness, or giving away personal items require immediate suicide risk assessment, environmental safety planning, and lethal means restriction.

• Geriatric Depression Scale vs. PHQ-9Geriatric Depression Scale (GDS): Specifically designed for older adults by minimizing somatic items (such as fatigue or constipation) that can overlap with physical medical conditions.

  • Geriatric Depression Scale (GDS): Specifically designed for older adults by minimizing somatic items (such as fatigue or constipation) that can overlap with physical medical conditions.
  • PHQ-9: Standardized 9-item tool assessing both somatic and cognitive symptoms of depression, validated across adult age groups including long-term care settings.
• Geriatric Depression Scale vs. Cornell Scale for Depression in DementiaGeriatric Depression Scale (GDS): Relies on patient self-report using a simple yes or no format, requiring mild to intact cognitive function.

  • Geriatric Depression Scale (GDS): Relies on patient self-report using a simple yes or no format, requiring mild to intact cognitive function.
  • Cornell Scale for Depression in Dementia: Utilizes clinician observation and informant interviews to evaluate depressive symptoms in patients with moderate to severe dementia who cannot self-report accurately.
• Mini-Cog vs. Montreal Cognitive Assessment (MoCA)Mini-Cog: A rapid 3-minute screening tool consisting of a 3-item word recall and a clock drawing test to detect general cognitive impairment.

  • Mini-Cog: A rapid 3-minute screening tool consisting of a 3-item word recall and a clock drawing test to detect general cognitive impairment.
  • MoCA: A comprehensive 30-point screening tool evaluating six cognitive domains (memory, executive function, language, visuospatial, attention, orientation) to detect mild cognitive impairment.
• Elder Abuse Realities1. Elder abuse prevalence: Most elder abuse occurs in domestic settings and is perpetrated by family members or primary caregivers, often going unreported due to fear of retaliation, guilt, or lack of alternative support.

  • 1. Elder abuse prevalence: Most elder abuse occurs in domestic settings and is perpetrated by family members or primary caregivers, often going unreported due to fear of retaliation, guilt, or lack of alternative support.
  • 2. Abuse classification: Types of elder abuse include physical abuse, emotional or psychological abuse, sexual abuse, financial exploitation, caregiver neglect, and self-neglect.
  • 3. Mandatory reporting: Advanced practice nurses are mandatory reporters required to notify Adult Protective Services immediately upon reasonable suspicion of elder abuse, neglect, or financial exploitation.
  • 4. Caregiver burden: Neuropsychiatric symptoms occur in 98% of patients with major neurocognitive disorder and directly drive caregiver burnout, high healthcare costs, and early nursing home placement.
  • 5. First-line interventions: Non-pharmacological strategies such as adult day centers, respite care, support groups, and home safety modifications are first-line choices to relieve caregiver strain and enable aging in place.
  • 6. Antipsychotic boxed warning: A safety alert applies to all antipsychotics due to a 1.6 to 1.7 times increased risk of mortality in older adults with dementia-related psychosis, primarily from cardiovascular events or pneumonia.
• Elder Abuse Types, Signs, and PerpetratorsPerpetrator demographics: Family members and co-residing primary caregivers account for the majority of elder abuse cases, frequently driven by caregiver stress, substance use, or financial dependency.

  • Perpetrator demographics: Family members and co-residing primary caregivers account for the majority of elder abuse cases, frequently driven by caregiver stress, substance use, or financial dependency.
  • Physical indicators: Unexplained fractures, bruises in various stages of healing, lacerations, burns, or traumatic hair loss require immediate clinical investigation.
  • Neglect indicators: Malnutrition, dehydration, unmanaged pressure ulcers, dirty clothing, unfulfilled prescriptions, or hazardous living conditions signify caregiver neglect.
  • Financial exploitation: Unexplained withdrawals from bank accounts, sudden changes to wills or legal documents, or missing personal property indicate financial abuse.
  • Reporting mandate: Reasonable suspicion obligates the provider to report to Adult Protective Services. Proof is not required, and patient consent is not needed to file a report.
• Caregiver Burden and Support StrategiesPrevalence of behavioral symptoms: Neuropsychiatric symptoms affect 98% of patients with major neurocognitive disorder, causing severe caregiver exhaustion and distress.

  • Prevalence of behavioral symptoms: Neuropsychiatric symptoms affect 98% of patients with major neurocognitive disorder, causing severe caregiver exhaustion and distress.
  • Respite and day programs: Adult day centers provide structured social activities for the patient while giving caregivers essential respite to prevent burnout.
  • Home safety modifications: Essential interventions include stove shut-off devices, door alarms for wandering prevention, fall risk reduction, and financial protection from scams.
  • Advance directives: Establishing advance care planning early ensures patient preferences regarding aggressive medical interventions are documented before severe cognitive decline occurs.
• Caregiver Neglect vs. Self-NeglectThink Caregiver Neglect: Failure of an assigned caregiver to fulfill obligations for food, shelter, clothing, medical care, or hygiene.

  • Think Caregiver Neglect: Failure of an assigned caregiver to fulfill obligations for food, shelter, clothing, medical care, or hygiene.
  • Think Self-Neglect: Failure of an isolated older adult with cognitive or physical impairment to perform basic self-care tasks.
  • Priority: Caregiver neglect requires mandatory reporting to Adult Protective Services. Self-neglect requires functional capacity assessment and community support services.
• Delirium-Induced Agitation vs. Behavioral Symptoms of DementiaThink Delirium-Induced Agitation: Abrupt onset over hours to days, fluctuating course, impaired attention, and an acute underlying physical cause like urinary tract infection or hyponatremia.

  • Think Delirium-Induced Agitation: Abrupt onset over hours to days, fluctuating course, impaired attention, and an acute underlying physical cause like urinary tract infection or hyponatremia.
  • Think Behavioral Symptoms of Dementia: Gradual onset over months, stable level of consciousness, triggered by routine disruption or environmental overload.
  • Priority: Delirium requires urgent medical evaluation and correction of the physical trigger. Dementia-related behavioral symptoms require non-pharmacological redirection and caregiver support.
• Caregiver Burden EducationCaregiver burden correlates directly with the severity of neuropsychiatric symptoms (NPS), which occur in 98% of patients with major neurocognitive disorder (NCD).

  • Caregiver burden correlates directly with the severity of neuropsychiatric symptoms (NPS), which occur in 98% of patients with major neurocognitive disorder (NCD).
  • Up to 50% of patients with major neurocognitive disorder experience co-occurring depression, making mood screening with tools like the PHQ-9 essential.
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) provide minor, time-limited cognitive benefits in mild-to-moderate Alzheimer's disease; they do not restore pre-disease baseline. Common side effects are nausea and diarrhea.
  • Antipsychotics (SGAs like brexpiprazole, quetiapine, risperidone) carry an FDA black box warning for an increased mortality risk of 1.6 to 1.7 times placebo in dementia-related psychosis due to cardiovascular events or pneumonia.
  • Non-pharmacologic interventions to support caregivers and allow aging in place include adult day centers, home safety plans (stove shutoff timers, door alarms), fall prevention, and structured daily routines.
  • Sudden changes in mental status in older adults indicate delirium rather than progressive dementia and require immediate medical evaluation to identify acute underlying causes like hyponatremia or infection.
• Caregiver Burden and Clinical FrameworkWord-finding difficulties and expressive language loss.

  • Word-finding difficulties and expressive language loss.
  • Unpredictable angry outbursts triggered by minor environmental changes or routine disruptions.
  • Apathy and emotional withdrawal, where the patient appears unengaged in daily activities.
  • 1. Connecting families early to community resources such as the Alzheimer's Association.
  • 2. Facilitating legal, financial, and end-of-life care planning while the patient retains decision-making capacity.
  • 3. Utilizing adult day centers to provide structured patient engagement and essential caregiver respite.
• The Four As and MoreMajor neurocognitive disorder requires demonstrable cognitive decline from a prior baseline in one or more of six cognitive domains: learning and memory, executive function, language, perceptual-motor, complex attention, and social cognition.

  • Major neurocognitive disorder requires demonstrable cognitive decline from a prior baseline in one or more of six cognitive domains: learning and memory, executive function, language, perceptual-motor, complex attention, and social cognition.
  • Additional high-yield cognitive screening clue words include perseveration (unintentional repetition of words, phrases, or actions), anomia (inability to name familiar items), and executive dysfunction (loss of planning, organizing, and abstract reasoning).
  • First-line pharmacotherapy for mild-to-moderate Alzheimer's disease consists of cholinesterase inhibitors (donepezil, rivastigmine, galantamine), while memantine is added for moderate-to-severe stages.
  • All antipsychotics carry an FDA boxed warning for increased mortality (1.6 to 1.7 times higher, primarily from sudden cardiac events or pneumonia) when used in older adults with dementia-related psychosis.
  • Dementia with Lewy bodies presents with early visual hallucinations, REM sleep behavior disorder, and severe extrapyramidal hypersensitivity to antipsychotics; prominent short-term memory loss is typically absent in early stages.
  • Delirium is distinguished from dementia by its acute onset over hours to days, fluctuating course throughout the day, and primary disturbance in attention and awareness.

  Board trap. Dementia with Lewy bodies presents with early visual hallucinations, REM sleep behavior disorder, and severe extrapyramidal hypersensitivity to antipsychotics; prominent short-term memory loss is typically absent in early stages.

  Safety. All antipsychotics carry an FDA boxed warning for increased mortality (1.6 to 1.7 times higher, primarily from sudden cardiac events or pneumonia) when used in older adults with dementia-related psychosis.

• The Four As DefinedAgnosia: Failure to recognize or identify familiar objects, sounds, or family members despite intact primary visual, auditory, and tactile perception.

  • Agnosia: Failure to recognize or identify familiar objects, sounds, or family members despite intact primary visual, auditory, and tactile perception.
  • Amnesia: Profound deficit in forming new memories or retrieving established memories. Patients with major neurocognitive disorder restate the same thought or repeat the same question multiple times within a single interaction.
• Related Cognitive Screening ConceptsPerseveration: The continuous, inappropriate repetition of a previously requested word, phrase, movement, or concept beyond the context in which it was initiated.

  • Perseveration: The continuous, inappropriate repetition of a previously requested word, phrase, movement, or concept beyond the context in which it was initiated.
  • Anomia: Specific inability to recall the names of common objects, forcing the patient to describe the object's function instead of stating its name.
• Differential Diagnosis and Clinical FeaturesContrast of Cognitive Domains in Neurocognitive Decline:

  • Contrast of Cognitive Domains in Neurocognitive Decline:
  • Memory and learning: Mild NCD shows increased reliance on calendar lists and delayed recall errors. Major NCD shows frequent restating of sentences within the same conversation and loss of task orientation.
  • Executive function: Mild NCD requires extra cognitive effort and causes mental fatigue during multi-step planning. Major NCD forces complete reliance on others to plan IADLs or causes abandonment of complex tasks.
  • Language: Mild NCD features subtle word-finding delays and minor grammatical errors. Major NCD features frequent use of vague terms and loss of specific noun usage.
  • Perceptual-motor: Mild NCD shows subtle spatial disorientation when unassisted. Major NCD causes significant inability to navigate familiar environments or operate tools.
  • Contrast of The Three Ds:
• Clinical Practice SignpostsInitiate a cholinesterase inhibitor (donepezil, rivastigmine, or galantamine) for mild-to-moderate Alzheimer's disease. These agents provide modest, time-limited cognitive stabilization but do not restore functioning to pre-disease baseline.

  • Initiate a cholinesterase inhibitor (donepezil, rivastigmine, or galantamine) for mild-to-moderate Alzheimer's disease. These agents provide modest, time-limited cognitive stabilization but do not restore functioning to pre-disease baseline.
  • Avoid prescribing tricyclic antidepressants like amitriptyline or sedating antihistamines like diphenhydramine in older adults. Their potent anticholinergic profile triggers acute delirium, confusion, urinary retention, severe dry mouth, and falls.
  • Monitor serum sodium closely when initiating SSRIs (such as sertraline) in older adults, especially those taking concomitant thiazide diuretics like hydrochlorothiazide. SSRI-induced hyponatremia presents with acute confusion, gait instability, and increased fall risk.

  Board trap. Avoid prescribing tricyclic antidepressants like amitriptyline or sedating antihistamines like diphenhydramine in older adults. Their potent anticholinergic profile triggers acute delirium, confusion, urinary retention, severe dry mouth, and falls.

  Safety. Monitor serum sodium closely when initiating SSRIs (such as sertraline) in older adults, especially those taking concomitant thiazide diuretics like hydrochlorothiazide. SSRI-induced hyponatremia presents with acute confusion, gait instability, and increased fall risk.

• Neurological Exam SignsUp to 50% of patients with major neurocognitive disorder also suffer from co-occurring major depressive disorder, making depression, dementia, and delirium the primary clinical triad in geriatric psychiatry.

  • Up to 50% of patients with major neurocognitive disorder also suffer from co-occurring major depressive disorder, making depression, dementia, and delirium the primary clinical triad in geriatric psychiatry.
  • Delirium is characterized by an abrupt onset over hours to days, a fluctuating course, and a primary disturbance in attention and awareness, whereas major neurocognitive disorder features an insidious, progressive cognitive decline.
  • In patients with Lewy body disease, low-dose second-generation antipsychotics trigger severe neuroleptic sensitivity, precipitating marked extrapyramidal symptoms, severe bradycardia, rigidity, and elevated mortality.
  • Cholinesterase inhibitors (such as donepezil, rivastigmine, and galantamine) demonstrate the greatest clinical benefit in mild to moderate Alzheimer disease, whereas memantine (an NMDA receptor antagonist) is indicated for moderate to severe Alzheimer disease.
  • Tricyclic antidepressants (TCAs) like amitriptyline must be avoided in older adults due to severe anticholinergic toxicity, orthostatic hypotension, and increased fall or fracture risks under the Beers criteria.
• AsterixisWhat it is: Bilateral, involuntary flapping movements of outstretched hands caused by sudden intermittent loss of motor tone.

  • What it is: Bilateral, involuntary flapping movements of outstretched hands caused by sudden intermittent loss of motor tone.
  • Why boards care: Serves as a classic physical exam marker for metabolic encephalopathy and acute organ failure.
  • Triggered by asking the patient to extend their wrists with fingers spread apart.
  • Typical board clue: Flapping wrist tremor in a confused older adult with elevated liver enzymes or elevated blood urea nitrogen.
  • First-line approach: Identify and treat the underlying systemic metabolic cause, such as hepatic failure or acute renal failure.
  • Asterixis signals severe metabolic delirium that requires immediate medical stabilization before any psychiatric diagnosis is assigned.

  Safety. Asterixis signals severe metabolic delirium that requires immediate medical stabilization before any psychiatric diagnosis is assigned.

• NystagmusWhat it is: Involuntary, rapid, rhythmic oscillation of the eyes.

  • What it is: Involuntary, rapid, rhythmic oscillation of the eyes.
  • Why boards care: Differentiates toxic-metabolic or neurological emergencies from primary psychiatric disorders.
  • Can be horizontal, vertical, or rotatory; horizontal nystagmus is frequently associated with central nervous system depressant toxicity or thiamine deficiency.
  • Typical board clue: Ataxia, confusion, and ophthalmoplegia/nystagmus in a patient with chronic alcohol use.
  • First-line approach: Administer high-dose parenteral thiamine immediately prior to glucose administration to treat or prevent Wernicke encephalopathy.
  • Giving intravenous glucose before thiamine in a patient with nystagmus and alcohol use can precipitate irreversible Korsakoff psychosis.

  Board trap. Giving intravenous glucose before thiamine in a patient with nystagmus and alcohol use can precipitate irreversible Korsakoff psychosis.

• MyoclonusWhat it is: Sudden, brief, involuntary shock-like muscle contractions.

  • What it is: Sudden, brief, involuntary shock-like muscle contractions.
  • Why boards care: Distinguishes rapidly progressive neurocognitive disorders, severe drug toxicities, or metabolic encephalopathies from uncomplicated dementia.
  • Present in toxic states, severe delirium, end-stage neurocognitive disorders, and Creutzfeldt-Jakob disease.
  • Typical board clue: Sudden muscle jerks in an elderly patient with acute confusion or rapidly worsening cognitive decline.
  • First-line approach: Perform an urgent medical evaluation and review all current medications for neurotoxic accumulation or drug interactions.
• Kayser-Fleischer RingsWhat it is: Golden-brown or brownish-green copper deposits in the Descemet membrane of the cornea.

  • What it is: Golden-brown or brownish-green copper deposits in the Descemet membrane of the cornea.
  • Why boards care: Pathognomonic physical finding for Wilson disease, an autosomal recessive disorder of copper metabolism that mimics psychiatric illness.
  • Best identified via slit-lamp ophthalmic examination.
  • Typical board clue: Young or middle-aged adult presenting with unexplained psychosis, personality changes, asterixis, tremor, and liver dysfunction.
  • First-line approach: Order serum ceruloplasmin and 24-hour urinary copper excretion tests, then initiate copper-chelating therapy.
• Delirium vs. Major Neurocognitive DisorderDo not confuse: Acute, reversible fluctuation versus chronic, irreversible decline.

  • Do not confuse: Acute, reversible fluctuation versus chronic, irreversible decline.
  • Think delirium when: Onset is abrupt over hours to days, course fluctuates, and the cardinal feature is impaired attention and awareness.
  • Think major neurocognitive disorder when: Onset is insidious over months to years, course is progressive, and attention remains relatively intact in early stages.
  • Priority difference: Delirium is a medical emergency requiring immediate identification of the underlying physical cause; major neurocognitive disorder requires long-term functional and safety planning.
  • What boards are really testing: Ruling out acute medical causes before diagnosing dementia or depression.
  • Classic distractor: Assuming acute confusion in an elderly patient is a normal part of aging or routine dementia progression.
• Lewy Body Disease vs. Alzheimer DiseaseDo not confuse: Early visual hallucinations and parkinsonism versus early short-term memory loss.

  • Do not confuse: Early visual hallucinations and parkinsonism versus early short-term memory loss.
  • Think Lewy body disease when: Patient presents with early visual hallucinations, fluctuating cognition, REM sleep behavior disorder, and parkinsonian motor signs within one year of cognitive decline.
  • Think Alzheimer disease when: Patient presents with insidious short-term memory impairment and progressive deficit in learning and executive function without early extrapyramidal signs.
  • Priority difference: Patients with Lewy body disease have extreme sensitivity to antipsychotics, which can trigger severe rigidity, catatonia, or death.
  • Prescribing haloperidol or risperidone for agitation in Lewy body disease.

  Board trap. Prescribing haloperidol or risperidone for agitation in Lewy body disease.

• Trap 1: Ordering a head CT scan before basic laboratory workup for acute confusionWhy it looks right: Neuroimaging evaluates structural brain lesions.

  • Why it looks right: Neuroimaging evaluates structural brain lesions.
  • Why it is wrong: Acute mental status changes in older adults are far more frequently caused by metabolic derangements, infections, or hypoxia than structural brain lesions.
  • What makes the correct answer better: Laboratory tests (CBC, CMP, urinalysis, glucose) and an EKG identify the most common reversible causes faster and more cost-effectively.
  • Board rule to remember: First-line evaluation for acute delirium begins with non-invasive lab testing and vital signs before ordering brain imaging unless focal neurological deficits or trauma are documented.
• Trap 2: Prescribing a second-generation antipsychotic for mild behavioral outburstsWhy it looks right: Antipsychotics are used for agitation and psychosis.

  • Why it looks right: Antipsychotics are used for agitation and psychosis.
  • Why it is wrong: All antipsychotics carry an FDA boxed warning for increased mortality in older adults with dementia-related psychosis, primarily from cardiovascular events or pneumonia.
  • What makes the correct answer better: Environmental modifications, routine stabilization, and non-pharmacological interventions are preferred first; antipsychotics are reserved strictly for severe agitation that poses an immediate safety risk.
  • Board rule to remember: Safety alert: Antipsychotics in elderly patients with neurocognitive disorders carry a 1.6 to 1.7 times increased risk of death.
• C) Serum ceruloplasmin levelQuick Answer: The PMHNP should order a comprehensive metabolic panel and complete blood count initially.

  • Quick Answer: The PMHNP should order a comprehensive metabolic panel and complete blood count initially.
  • Key Clue: Acute onset over two days with impaired attention and asterixis (wrist-flapping tremor).
  • Best Answer: B) Comprehensive metabolic panel and complete blood count
  • Why the Other Choices Are Wrong:
  • A: A head CT scan is less essential initially for acute delirium unless focal neurological signs, head trauma, or papilledema are present.
  • C: Serum ceruloplasmin screens for Wilson disease, which typically presents in younger individuals rather than an acute 80-year-old presentation.
• C) Ordering a comprehensive medication reconciliationQuick Answer: Initiating standard-dose haloperidol represents the most significant safety risk.

  • Quick Answer: Initiating standard-dose haloperidol represents the most significant safety risk.
  • Key Clue: Visual hallucinations, fluctuating alertness, and dream enactment indicate Lewy body disease / Parkinson disease dementia.
  • Best Answer: B) Initiating standard-dose haloperidol
  • Why the Other Choices Are Wrong:
  • A: Quetiapine is one of the preferred low-potency options if an antipsychotic is absolutely necessary, carrying a lower risk of extrapyramidal worsening.
  • C: Medication reconciliation is a safe and necessary step to identify anticholinergic or dopaminergic triggers.
• C) Liver function testsQuick Answer: Human immunodeficiency virus (HIV) screening is the least essential initial test for sudden onset mental status change.

  • Quick Answer: Human immunodeficiency virus (HIV) screening is the least essential initial test for sudden onset mental status change.
  • Key Clue: Sudden onset over four hours indicates acute delirium requiring immediate reversible cause screening.
  • Best Answer: D) Human immunodeficiency virus (HIV) screening
  • Why the Other Choices Are Wrong:
  • A: Serum glucose rapidly identifies hypoglycemia or severe hyperglycemia as a cause of acute confusion.
  • B: Urinalysis quickly screens for urinary tract infection, a leading cause of delirium in older females.